[
{
  "id": "page12.scheme0",
  "input": [
    {
      "role": "system",
      "content": "\nYou are a chemical synthesis extraction agent. Extract **each synthesis step** from chemical patent text, with no inference across steps. Preserve wording and IDs exactly.\n\n# Input\nPatent text is tagged as:\n- <text id=...> ... </text>\n- <mol id=...> ... </mol>\n- <table id=...> ... </table>\n- <scheme id=...> ... </scheme>\nTags are top-level, ordered, and IDs must not be changed.\n\n# Extraction Fields\n1. compound_id  \n   - Use explicit product labels (e.g., \"Compound 2\", \"Intermediate A\").  \n   - If only section title defines the final product, assign section title (only last step).  \n   - Otherwise \"\".\n2. iupac_name  \n   - Use if explicitly given; otherwise \"\". No inference.\n3. structure_id  \n   - Only link <mol> ID if it shows the **final product** of the whole Example/Section. Else \"\".\n4. detail_ids  \n   - List of <text id=...> blocks describing procedure (exclude pure analytical data).\n5. detail  \n   - Concatenated verbatim text of detail_ids. No paraphrasing.\n6. refs  \n   - Compound identifiers referenced as inputs. Use exact labels. If none, null.\n\n# Output Format\n```json\n{\n  \"results\": [\n    {\n      \"compound_id\": \"...\",\n      \"iupac_name\": \"...\",\n      \"structure_id\": \"...\",\n      \"detail_ids\": [\"...\"],\n      \"detail\": \"...\",\n      \"refs\": [...] or null\n    }\n  ]\n}\n```\n\n# Rules\n1. One record per step; split at \"Step\" or clear process transitions.\n2. Never merge steps.\n3. No cross-step inference.\n4. Use section title as compound_id only for the last product-forming step.\n5. Accept phrases like \"title compound\" only as reference, not as identifiers.\n\n# Restriction\n1. Retain all <sub> and <sup> tags and their contents exactly as in the source text.\n\n\n## fewshot\nInput:\n```\n<text id=p43.i5>\nExample 37\n</text>\n<mol id=p43.i6>\npage_43.mol_0\n</mol>\n<text id=p43.i7>\n(S)-2-tert-Butoxy-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-2,3'-\nbipyridin-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (50 mg,0.103\nmmol) in DMF (10 mL) was added K2CO3(14.29 mg,0.103 mmol) and 1-bromobutane\n(14.17 mg,0.103 mmol). Then, the mixture was stirred for 20 hours at 45 °℃ and diluted\nwith water and ethyl acetate (30 mL). Organic layer separated, washed with brine (20 mL),\ndried over Na2SO4 and concentrated to obtain a crude product, which was purified by silica\n</text>\n<text id=p44.i0>\ngel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford\nisopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-\n[2,3'-bipyridin]-5'-yl)acetate (43 mg, 0.080 mmol, 77% yield) as a yellow oil.LCMS(M+\nH)=540.2; Retention time (10 mM NH4HCO3)=2.758.\n</text>\n<text id=p44.i1>\nStep 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (52 mg, 0.096 mmol) in\nmethanol (10 mL) and water (2 mL) was added sodium hydroxide (11.56 mg, 0.289 mmol)\nand stirred for 20 hours at 100°C.The mixture was concentrated under vacuo, diluted with\nHCl (1N,0.5 ml), extracted with ethyl acetate (5 ml) and concentrated to give crude\nproduct. The crude product was purified by Prep-HPLC {Instrument Gilson 281 (PHG-\n009); Column Xtimate Prep C18 OBD,21.2 x 250 mm,10 um; Mobile Phase A:water (10\nmM NH4HCO3); B:MeCN; Gradient 40-68%B in 8.0 min,stop at 13.0 min; Flow Rate\n(ml/min)30.00} togive (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-\nyl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetic acid (21.6 mg,0.042 mmol, 43.9 % yield) as\nwhite solid.LCMS(M+H)=498.1; Retention time(10 mM NH4HCO3)=1.716.lH\nNMR(400 MHz,MeOD)δ8.36(d,J=2.8Hz,1H), 8.17(s,1H), 7.56(dd, J=8.6,2.9 Hz,\n1H),7.47(d,J=8.6Hz,1H),5.82(s,1H),4.16(t,J=6.4Hz,2H),2.30-2.66(m,7H),\n1.91-1.77(m,2H),1.64-1.25(m,8H),1.21(s,9H),1.04(t,J=7.4Hz,3H),0.88-0.77\n(m, 6H).\n</text>\n<text id=p44.i4>\nExample 38\n</text>\n<mol id=p44.i5>\npage_44.mol_0\n</mol>\n<text id=p44.i6>\n(S)-2-tert-Butoxy-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-6'-methyl-2,3'-bipyridin-5'-yl)acetic acid\nStep 1: To a solution of 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethan-1-ol (250 mg,1.783\nmmol) and triethylamine (271 mg,2.68 mmol) in DCM (10 mL) was added methanesulfonyl\nchloride (225 mg, 1.962 mmol) at 0°℃. The mixture was stirred at rt for 1 h. The mixture\nwas taken up into aqueous Na2CO3 (20 mL) and extracted with DCM (10 ml X 3). The\n</text>\n<text id=p45.i0>\ncombined organic layers were washed with brine, dried over Na2SO4, concentrated to afford\n2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl methanesulfonate (300 mg, 1.100 mmol, 61.7 %\nyield) as oil which was used in the next step without further purification. LCMS: retention\ntime = 1.22 min, m/z = 219 [M+H]<sup>+</sup>, purity: 80% (214 nm).\n</text>\n<text id=p45.i1>\nStep 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (50 mg, 0.103\nmmol) in DMF (10 mL) was added K<sub>2</sub>CO<sub>3</sub> (71.4 mg, 0.517 mmol) and 2-(1,3-dimethyl-\n1H-pyrazol-4-yl)ethyl methanesulfonate (67.7 mg, 0.310 mmol). Then, the mixture was\nstirred for 20 hours at 45 °C and diluted with water and ethyl acetate (30 mL). Organic\nlayer separated, washed with brine (20 mL), dried over Na2SO<sub>4</sub> and concentrated to obtain\na crude product, which was purified by silica gel chromatography eluting with ethyl\nacetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (S)-2-(tert-butoxy)-2-(5-(2-\n(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-\nbipyridin]-5'-yl)acetate (41 mg, 0.068 mmol, 65.5 % yield) as a yellow oil. LCMS (M + H)\n= 606.2; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 2.234.\n</text>\n<text id=p45.i3>\nStep 3: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-\npyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-\nyl)acetate (41 mg, 0.068 mmol) in methanol (10 mL) and water (2 mL) was added sodium\nhydroxide (8.12 mg, 0.203 mmol) and stirred for 20 hours at 100 °C. The mixture was\nconcentrated under vacuo, diluted with HCl (1N, 0.5 ml), extracted with ethyl acetate (5\nml) and concentrated to give crude product. The crude product was purified by Prep-HPLC\n{Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2 x 250 mm, 10\num; Mobile Phase A: water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0\nmin, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (S)-2-(tert-butoxy)-2-(5-(2-(1,3-\ndimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-\nbipyridin]-5'-yl) acetic acid (17.3 mg, 0.031 mmol, 45.3 % yield) as white solid. LCMS (M\n+ H) = 564.2; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 1.452. <sup>1</sup>H NMR (400 MHz, MeOD) δ\n8.38 (d, J = 2.7 Hz, 1H), 8.16 (s, 1H), 7.56 (dd, J = 8.6, 2.9 Hz, 1H), 7.47 (d, J = 7.8 Hz,\n2H), 5.82 (s, 1H), 4.25 (t, J = 6.7 Hz, 2H), 3.80 (s, 3H), 3.23-2.57 (m, 9H), 2.25 (s, 3H),\n1.61-1.23 (m, 6H), 1.21 (s, 9H), 0.87- 0.74 (m, 6H).\n</text>\n```\nOutput:\n```json\n{\n    \"results\": [\n        {\n        \"compound_id\": \"Example 37.Step 1\",\n        \"iupac_name\": \"isopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate\",\n        \"structure_id\": \"\",\n        \"detail_ids\": [\n            \"p43.i7\",\n            \"p44.i0\"\n        ],\n        \"detail\": \"Step 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-methylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (50 mg,0.103 mmol) in DMF (10 mL) was added K2CO3(14.29 mg,0.103 mmol) and 1-bromobutane (14.17 mg,0.103 mmol). Then, the mixture was stirred for 20 hours at 45 °℃ and diluted with water and ethyl acetate (30 mL). Organic layer separated, washed with brine (20 mL), dried over Na2SO4 and concentrated to obtain a crude product, which was purified by silica\ngel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (43 mg, 0.080 mmol, 77% yield) as a yellow oil.LCMS(M+ H)=540.2; Retention time (10 mM NH4HCO3)=2.758.\",\n        \"refs\": null\n        },\n        {\n        \"compound_id\": \"Example 37.Step2\",\n        \"iupac_name\": \"(S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetic acid\",\n        \"structure_id\": \"page_43.mol_0\",\n        \"detail_ids\": [\n            \"p44.i1\"\n        ],\n        \"detail\": \"Step 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (52 mg, 0.096 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide (11.56 mg, 0.289 mmol) and stirred for 20 hours at 100°C.The mixture was concentrated under vacuo, diluted with HCl (1N,0.5 ml), extracted with ethyl acetate (5 ml) and concentrated to give crude product. The crude product was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD,21.2 x 250 mm,10 um; Mobile Phase A:water (10 mM NH4HCO3); B:MeCN; Gradient 40-68%B in 8.0 min,stop at 13.0 min; Flow Rate (ml/min)30.00} togive (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetic acid (21.6 mg,0.042 mmol, 43.9 % yield) as white solid.LCMS(M+H)=498.1; Retention time(10 mM NH4HCO3)=1.716.lH NMR(400 MHz,MeOD)δ8.36(d,J=2.8Hz,1H), 8.17(s,1H), 7.56(dd, J=8.6,2.9 Hz, 1H),7.47(d,J=8.6Hz,1H),5.82(s,1H),4.16(t,J=6.4Hz,2H),2.30-2.66(m,7H), 1.91-1.77(m,2H),1.64-1.25(m,8H),1.21(s,9H),1.04(t,J=7.4Hz,3H),0.88-0.77 (m, 6H).\",\n        \"refs\": null\n        },\n        {\n        \"compound_id\": \"Example 38.Step 1\",\n        \"iupac_name\": \"2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl methanesulfonate\",\n        \"structure_id\": \"\",\n        \"detail_ids\": [\n            \"p44.i6\",\n            \"p45.i0\"\n        ],\n        \"detail\": \"Step 1: To a solution of 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethan-1-ol (250 mg,1.783 mmol) and triethylamine (271 mg,2.68 mmol) in DCM (10 mL) was added methanesulfonyl chloride (225 mg, 1.962 mmol) at 0°℃. The mixture was stirred at rt for 1 h. The mixture was taken up into aqueous Na2CO3 (20 mL) and extracted with DCM (10 ml X 3). The\ncombined organic layers were washed with brine, dried over Na2SO4, concentrated to afford 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl methanesulfonate (300 mg, 1.100 mmol, 61.7 % yield) as oil which was used in the next step without further purification. LCMS: retention time = 1.22 min, m/z = 219 [M+H]<sup>+</sup>, purity: 80% (214 nm).\",\n        \"refs\": null\n        },\n        {\n        \"compound_id\": \"Example 38.Step 2\",\n        \"iupac_name\": \"isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate\",\n        \"structure_id\": \"\",\n        \"detail_ids\": [\n            \"p45.i1\"\n        ],\n        \"detail\": \"Step 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-methylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (50 mg, 0.103 mmol) in DMF (10 mL) was added K<sub>2</sub>CO<sub>3</sub> (71.4 mg, 0.517 mmol) and 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl methanesulfonate (67.7 mg, 0.310 mmol). Then, the mixture was stirred for 20 hours at 45 °C and diluted with water and ethyl acetate (30 mL). Organic layer separated, washed with brine (20 mL), dried over Na2SO<sub>4</sub> and concentrated to obtain a crude product, which was purified by silica gel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (41 mg, 0.068 mmol, 65.5 % yield) as a yellow oil. LCMS (M + H) = 606.2; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 2.234.\",\n        \"refs\": null\n        },\n        {\n        \"compound_id\": \"Example 38.Step 3\",\n        \"iupac_name\": \"(S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl) acetic acid\",\n        \"structure_id\": \"page_44.mol_0\",\n        \"detail_ids\": [\n            \"p45.i3\"\n        ],\n        \"detail\": \"Step 3: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (41 mg, 0.068 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide (8.12 mg, 0.203 mmol) and stirred for 20 hours at 100 °C. The mixture was concentrated under vacuo, diluted with HCl (1N, 0.5 ml), extracted with ethyl acetate (5 ml) and concentrated to give crude product. The crude product was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2 x 250 mm, 10 um; Mobile Phase A: water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl) acetic acid (17.3 mg, 0.031 mmol, 45.3 % yield) as white solid. LCMS (M + H) = 564.2; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 1.452. <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.38 (d, J = 2.7 Hz, 1H), 8.16 (s, 1H), 7.56 (dd, J = 8.6, 2.9 Hz, 1H), 7.47 (d, J = 7.8 Hz, 2H), 5.82 (s, 1H), 4.25 (t, J = 6.7 Hz, 2H), 3.80 (s, 3H), 3.23-2.57 (m, 9H), 2.25 (s, 3H), 1.61-1.23 (m, 6H), 1.21 (s, 9H), 0.87- 0.74 (m, 6H).\",\n        \"refs\": null\n        }\n    ]\n}\n```\n\n## fewshot\n1. refs is only used to record other compound identifiers explicitly referenced during the synthesis of this product (e.g., Example XX). If no such identifiers are mentioned, set refs: null.\nInput:\n```\n<scheme id=p12.i9>\n| id             | reactant      | condition   | product       |\n|:---------------|:--------------|:------------|:--------------|\n| page12.scheme0 | page_12.mol_0 |             | page_12.mol_1 |\n</scheme>\n<text id=p12.i10>\nTo a stirred solution of 2-methylpyridin-4-ol (8.0 g, 73 mmol)in dichloromethane\n(90 ml) and MeOH(11 ml) was added tert-butylamine (15.7 ml,148 mmol) and the\nmixture was cooled to 0 °C. Bromine (7.55 ml,147 mmol) was added dropwise over a 20\nminute period. The reaction mixture was stirred at rt for 2 hours. Then the resulting slurry\nwas filtered through a buchner funnel and the solid was washed with methanol (100 ml)\nand dried overnight to afford 3,5-dibromo-2-methylpyridin-4-ol (10g,37.5 mmol, 51.1%\nyield). LCMS Method 4:retention time = 0.704 min.; observed ion =267.8.lH NMR (500\nMHz,DMSO-d6)δ12.33(brs,1H),8.21(s,1H),2.40(s,3H).\n</text>\n```\nOutput:\n```json\n{\n    \"results\": [\n        {\n        \"compound_id\": \"\",\n        \"iupac_name\": \"3,5-dibromo-2-methylpyridin-4-ol\",\n        \"structure_id\": \"page_12.mol_1\",\n        \"detail_ids\": [\n            \"p12.i10\"\n        ],\n        \"detail\": \"To a stirred solution of 2-methylpyridin-4-ol (8.0 g, 73 mmol)in dichloromethane (90 ml) and MeOH(11 ml) was added tert-butylamine (15.7 ml,148 mmol) and the mixture was cooled to 0 °C. Bromine (7.55 ml,147 mmol) was added dropwise over a 20 minute period. The reaction mixture was stirred at rt for 2 hours. Then the resulting slurry was filtered through a buchner funnel and the solid was washed with methanol (100 ml) and dried overnight to afford 3,5-dibromo-2-methylpyridin-4-ol (10g,37.5 mmol, 51.1% yield). LCMS Method 4:retention time = 0.704 min.; observed ion =267.8.lH NMR (500 MHz,DMSO-d6)δ12.33(brs,1H),8.21(s,1H),2.40(s,3H).\",\n        \"refs\": null\n        }\n    ]\n}\n```\n\n## fewshot2\nThe current structure follows the following format:  \n1. First, this is an isomer example, with the Example Name shown at the top.  \n2. Under this Example, there are multiple Step blocks. Each step must use the top Example Name as the prefix in `compound_id`.  \n3. Each step corresponds to one product, so all steps must be separated into individual records.  \n4. The final step has associated structures. Both must be mapped back to the same Example Name, but output as separate records.  \nInput:\n```\n<text id=p75.i8>\nExample 65 and 66\n</text>\n<mol id=p76.i0>\npage_76.mol_0; page_76.mol_1\n</mol>\n<text id=p76.i1>\nFirst eluting isomer Second eluting isomer\n2S)-2-(tert-Butoxy)-2-(5-(cyclopropylmetl-xy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-\nyl)-[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate(50 mg,0.101 mmol)in\nDMF (10 mL) was added K2CO3 (41.8 mg, 0.303 mmol) and (bromomethyl)cyclopropane\n(27.2 mg,0.202 mmol). The mixture was stirred for 20 hours at 45°℃, diluted with water\nand ethyl acetate(30 mL),organic layer separated, washed with brine (20 mL),dried over\nNa2SO4 and concentrated to obtain a crude product which was purified by silica gel\nchromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1) to afford\nisopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (53 mg, 0.084 mmol, 84 %\nyield) as yellow oil. LCMS (M+H)=550.2; Retention time (10 mM NH4HCO3)=2.705\nmin.\n</text>\n<text id=p76.i5>\nStep 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-\n6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (52 mg,0.095\nmmol) in methanol (10 mL)and water (2 mL) was added sodium hydroxide (7.57 mg,\n0.189 mmol) and stirred for 20 hours at 100°C. The mixture was concentrated under\nvacuo, diluted with HCl (1N, 0.5 ml) and ethyl acetate (5ml). Organic layer separated and\nconcentrated to give crude product which was purified by Prep-HPLC {Instrument Gilson\n281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x250 mm, 10 um; Mobile Phase\nA: Water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0 min, stop at 13.0 min;\nFlow Rate (ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-\nmethyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (34.9 mg,\n0.069 mmol, 72.7% yield) as white solid.LCMS(M+H)=508.2; Retention time (10 mM\nNH4HCO3)=1.592 min.\n</text>\n<text id=p76.i7>\nStep 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-\nmethyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (32.1 mg,\n</text>\n<text id=p77.i0>\n0.063 mmol) were separated by SFC [Column AD-H 4.6x 100 mm; 5 um; Co-Solvent\nEtOH (1%ammonia/methanol)] to obtain\nFirst eluting diastereomer 65:(9.6 mg, 0.019 mmol,29.9% yield).LCMS(M+H)=\n508.2;Retention time (10 mM NH4HCO3) =1.605 min. lHNMR (400 MHz, MeOD) δ\n8.35(d,J=2.8Hz,1H),8.11 (s,1H), 7.54(dd,J=8.6,2.9 Hz, 1H), 7.45(d, J=8.6 Hz,\n1H),5.80(s,1H),4.00(d,J=7.0Hz,2H),2.66(s,3H),2.31-1.25(m,17H),1.18(s,9H),\n0.74-0.65(m,2H),0.50-0.34(m,2H)and\nSecond eluting diastereomer 66: (6.3 mg, 0.012 mmol, 19.63 % yield).LCMS (M+H)=\n508.0; Retention time (10 mM NH4HCO3) = 1.595 min. lH NMR (400 MHz, MeOD) δ\n8.23(d,J=2.7Hz,1H),7.98(s,1H),7.42(dd,J=8.6,2.8Hz,1H),7.33(d,J=8.6Hz,\n1H),5.78(s,1H),3.94-3.84(m,2H),2.52(s,3H),2.18-1.12(m,17H),1.07(s,9H),\n0.62-0.52(m,2H),0.31(q,J=4.6Hz,2H).\n</text>\n```\nOutput:\n```json\n{\n  \"results\": [\n      {\n          \"compound_id\": \"Example 65 and 66.Step 1\",\n          \"iupac_name\": \"isopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate\",\n          \"structure_id\": \"\",\n          \"detail_ids\": [\n              \"p76.i1\"\n          ],\n          \"detail\": \"Step 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate(50 mg,0.101 mmol)in DMF (10 mL) was added K2CO3 (41.8 mg, 0.303 mmol) and (bromomethyl)cyclopropane (27.2 mg,0.202 mmol). The mixture was stirred for 20 hours at 45°℃, diluted with water and ethyl acetate(30 mL),organic layer separated, washed with brine (20 mL),dried over Na2SO4 and concentrated to obtain a crude product which was purified by silica gel chromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1) to afford isopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (53 mg, 0.084 mmol, 84 % yield) as yellow oil. LCMS (M+H)=550.2; Retention time (10 mM NH4HCO3)=2.705 min.\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 65 and 66.Step 2\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"\",\n          \"detail_ids\": [\n              \"p76.i5\"\n          ],\n          \"detail\": \"Step 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (52 mg,0.095 mmol) in methanol (10 mL)and water (2 mL) was added sodium hydroxide (7.57 mg, 0.189 mmol) and stirred for 20 hours at 100°C. The mixture was concentrated under vacuo, diluted with HCl (1N, 0.5 ml) and ethyl acetate (5ml). Organic layer separated and concentrated to give crude product which was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x250 mm, 10 um; Mobile Phase A: Water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (34.9 mg, 0.069 mmol, 72.7% yield) as white solid.LCMS(M+H)=508.2; Retention time (10 mM NH4HCO3)=1.592 min.\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 65 and 66.Step 3\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"page_76.mol_0\",\n          \"detail_ids\": [\n              \"p76.i7\",\n              \"p77.i0\"\n          ],\n          \"detail\": \"Step 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (32.1 mg,\n0.063 mmol) were separated by SFC [Column AD-H 4.6x 100 mm; 5 um; Co-Solvent EtOH (1%ammonia/methanol)] to obtain\nFirst eluting diastereomer 65:(9.6 mg, 0.019 mmol,29.9% yield).LCMS(M+H)= 508.2;Retention time (10 mM NH4HCO3) =1.605 min. lHNMR (400 MHz, MeOD) δ 8.35(d,J=2.8Hz,1H),8.11 (s,1H), 7.54(dd,J=8.6,2.9 Hz, 1H), 7.45(d, J=8.6 Hz, 1H),5.80(s,1H),4.00(d,J=7.0Hz,2H),2.66(s,3H),2.31-1.25(m,17H),1.18(s,9H), 0.74-0.65(m,2H),0.50-0.34(m,2H)and Second eluting diastereomer 66: (6.3 mg, 0.012 mmol, 19.63 % yield).LCMS (M+H)= 508.0; Retention time (10 mM NH4HCO3) = 1.595 min. lH NMR (400 MHz, MeOD) δ 8.23(d,J=2.7Hz,1H),7.98(s,1H),7.42(dd,J=8.6,2.8Hz,1H),7.33(d,J=8.6Hz, 1H),5.78(s,1H),3.94-3.84(m,2H),2.52(s,3H),2.18-1.12(m,17H),1.07(s,9H), 0.62-0.52(m,2H),0.31(q,J=4.6Hz,2H).\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 65 and 66.Step 3\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"page_76.mol_1\",\n          \"detail_ids\": [\n              \"p76.i7\",\n              \"p77.i0\"\n          ],\n          \"detail\": \"Step 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (32.1 mg,\n0.063 mmol) were separated by SFC [Column AD-H 4.6x 100 mm; 5 um; Co-Solvent EtOH (1%ammonia/methanol)] to obtain\nFirst eluting diastereomer 65:(9.6 mg, 0.019 mmol,29.9% yield).LCMS(M+H)= 508.2;Retention time (10 mM NH4HCO3) =1.605 min. lHNMR (400 MHz, MeOD) δ 8.35(d,J=2.8Hz,1H),8.11 (s,1H), 7.54(dd,J=8.6,2.9 Hz, 1H), 7.45(d, J=8.6 Hz, 1H),5.80(s,1H),4.00(d,J=7.0Hz,2H),2.66(s,3H),2.31-1.25(m,17H),1.18(s,9H), 0.74-0.65(m,2H),0.50-0.34(m,2H)and Second eluting diastereomer 66: (6.3 mg, 0.012 mmol, 19.63 % yield).LCMS (M+H)= 508.0; Retention time (10 mM NH4HCO3) = 1.595 min. lH NMR (400 MHz, MeOD) δ 8.23(d,J=2.7Hz,1H),7.98(s,1H),7.42(dd,J=8.6,2.8Hz,1H),7.33(d,J=8.6Hz, 1H),5.78(s,1H),3.94-3.84(m,2H),2.52(s,3H),2.18-1.12(m,17H),1.07(s,9H), 0.62-0.52(m,2H),0.31(q,J=4.6Hz,2H).\",\n          \"refs\": null\n      }\n  ]\n}\n```\n\n## fewshot3\nThe current structure follows the following format:  \n1. First, this is an isomer example, with the Example Name shown at the top.\n2. Two structure_id values appear sequentially within the <mol> tags.\n3. The final step is associated with two structures. Both must be mapped back to the same Example Name, but output as separate records.\nInput:\n```\n<text id=p81.i1>\nExample 71 and 72\n</text>\n<mol id=p81.i2>\npage_81.mol_0\n</mol>\n<text id=p81.i3>\nFirst eluting isomer\n(2S)-2-(tert-Butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-\npyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (50mg, 0.101 mmol)in (10\nmL) was added K2CO3 (41.8 mg, 0.303 mmol) and 2-(tetrahydro-2H-pyran-4-yl)ethyl\nmethanesulfonate (31.5 mg,0.151 mmol).The mixture was stirred for 20 hours at 45°℃,\ndiluted with water and ethyl acetate(30 mL), organic layer separated, washed with brine\n(20 mL), dried over Na2SO4 and concentrated to obtain a crude product which was purified\nby silica gel chromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1)\nto afford isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-\n(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate (52 mg,0.082 mmol,\n81% yield) as yellow oil. LCMS (M+H)=608.2; Retention time (10 mM NH4HCO3)=\n2.649 min.\n</text>\n<text id=p81.i8>\nStep 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-\n5'-yl)acetate (52 mg, 0.086 mmol) in methanol (10 mL) and water (2 mL) was added\nsodium hydroxide (10.27 mg,0.257 mmol) and stirred for 20 hours at 100°C.The mixture\nwas concentrated under vacuo, diluted with HCl (1N,0.5 ml) and ethyl acetate (5ml).\nOrganic layer separated and concentrated to give crude product which was purified by\n</text>\n<mol id=p81.i11>\npage_81.mol_1\n</mol>\n<text id=p81.i12>\nSecond eluting isomer\n</text>\n<text id=p82.i0>\nPrep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x\n250 mm,10 um;Mobile Phase A: Water(10 mM NH4HCO3);B: MeCN;Gradient 40-\n68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (2S)-2-(tert-\nbutoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-\nyl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (21.5 mg,0.038 mmol, 44.4% yield) as white\nsolid.LCMS (M+H)=566.2;Retention time(10 mM NH4HCO3)=1.560 min.\n</text>\n<text id=p82.i2>\nStep 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-\n5'-yl)acetic acid (21.5 mg, 0.038 mmol) were separated by SFC [Column IC (4.6 x 100\nmm; 5 um); Co-Solvent MeOH (0.2%ammonia/methano)] to obtain\nFirst eluting diastereomer 71:(4.5 mg, 7.70 umol, 20.27% yield).LCMS (M+H)=566.1;\nRetention time(10 mM NH4HCO3)=1.558 min.lHNMR(400 MHz,MeOD) 8 8.37(d,J\n=2.8Hz,1H),8.13(s,1H),7.57(dd,J=8.6,2.9Hz,1H),7.46(d,J=8.6Hz,1H),5.82(s,\n1H), 4.23 (t, J=6.2 Hz,2H),3.97(dd, J= 11.1,3.4Hz,2H),3.47(td,J=11.9, 1.9 Hz,\n2H),2.66(s,3H),1.93-1.29(m,23H),1.20(s,9H) and\nSecond eluting diastereomer 72: (3.7mg, 6.54 umol, 17.21 % yield). LCMS (M+H)=\n566.2 ;Retention time (10 mM NH4HCO3)= 1.545 min. lHNMR (400 MHz, MeOD)δ\n8.26(d,J=2.7 Hz,1H),8.03 (s,1H),7.45(dd,J=8.6,2.9 Hz,1H),7.36(d,J=8.6Hz,\n1H),5.83(s,1H),4.11(t,J=6.1Hz,2H),3.85 (dd,J=10.9,3.7Hz,2H),3.34(td, J=\n11.9,2.0Hz,2H),2.52(s,3H),2.13-2.07(m,1H),1.98-1.16(m,23H),1.08(s,9H).\n</text>\n```\nOutput:\n```json\n{\n  \"results\": [\n      {\n          \"compound_id\": \"Example 71 and 72.Step 1\",\n          \"iupac_name\": \"isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate\",\n          \"structure_id\": \"\",\n          \"detail_ids\": [\n              \"p81.i3\"\n          ],\n          \"detail\": \"Step 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (50mg, 0.101 mmol)in (10 mL) was added K2CO3 (41.8 mg, 0.303 mmol) and 2-(tetrahydro-2H-pyran-4-yl)ethyl methanesulfonate (31.5 mg,0.151 mmol).The mixture was stirred for 20 hours at 45°℃, diluted with water and ethyl acetate(30 mL), organic layer separated, washed with brine (20 mL), dried over Na2SO4 and concentrated to obtain a crude product which was purified by silica gel chromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1) to afford isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate (52 mg,0.082 mmol, 81% yield) as yellow oil. LCMS (M+H)=608.2; Retention time (10 mM NH4HCO3)= 2.649 min.\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 71 and 72.Step 2\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"\",\n          \"detail_ids\": [\n              \"p81.i8\",\n              \"p82.i0\"\n          ],\n          \"detail\": \"Step 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate (52 mg, 0.086 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide (10.27 mg,0.257 mmol) and stirred for 20 hours at 100°C.The mixture was concentrated under vacuo, diluted with HCl (1N,0.5 ml) and ethyl acetate (5ml). Organic layer separated and concentrated to give crude product which was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x 250 mm,10 um;Mobile Phase A: Water(10 mM NH4HCO3);B: MeCN;Gradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (21.5 mg,0.038 mmol, 44.4% yield) as white solid.LCMS (M+H)=566.2;Retention time(10 mM NH4HCO3)=1.560 min.\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 71 and 72.Step 3\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"page_81.mol_0\",\n          \"detail_ids\": [\n              \"p82.i2\"\n          ],\n          \"detail\": \"Step 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (21.5 mg, 0.038 mmol) were separated by SFC [Column IC (4.6 x 100 mm; 5 um); Co-Solvent MeOH (0.2%ammonia/methano)] to obtain First eluting diastereomer 71:(4.5 mg, 7.70 umol, 20.27% yield).LCMS (M+H)=566.1; Retention time(10 mM NH4HCO3)=1.558 min.lHNMR(400 MHz,MeOD) 8 8.37(d,J =2.8Hz,1H),8.13(s,1H),7.57(dd,J=8.6,2.9Hz,1H),7.46(d,J=8.6Hz,1H),5.82(s, 1H), 4.23 (t, J=6.2 Hz,2H),3.97(dd, J= 11.1,3.4Hz,2H),3.47(td,J=11.9, 1.9 Hz, 2H),2.66(s,3H),1.93-1.29(m,23H),1.20(s,9H) and Second eluting diastereomer 72: (3.7mg, 6.54 umol, 17.21 % yield). LCMS (M+H)= 566.2 ;Retention time (10 mM NH4HCO3)= 1.545 min. lHNMR (400 MHz, MeOD)δ 8.26(d,J=2.7 Hz,1H),8.03 (s,1H),7.45(dd,J=8.6,2.9 Hz,1H),7.36(d,J=8.6Hz, 1H),5.83(s,1H),4.11(t,J=6.1Hz,2H),3.85 (dd,J=10.9,3.7Hz,2H),3.34(td, J= 11.9,2.0Hz,2H),2.52(s,3H),2.13-2.07(m,1H),1.98-1.16(m,23H),1.08(s,9H).\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 71 and 72.Step 3\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"page_81.mol_1\",\n          \"detail_ids\": [\n              \"p82.i2\"\n          ],\n          \"detail\": \"Step 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (21.5 mg, 0.038 mmol) were separated by SFC [Column IC (4.6 x 100 mm; 5 um); Co-Solvent MeOH (0.2%ammonia/methano)] to obtain First eluting diastereomer 71:(4.5 mg, 7.70 umol, 20.27% yield).LCMS (M+H)=566.1; Retention time(10 mM NH4HCO3)=1.558 min.lHNMR(400 MHz,MeOD) 8 8.37(d,J =2.8Hz,1H),8.13(s,1H),7.57(dd,J=8.6,2.9Hz,1H),7.46(d,J=8.6Hz,1H),5.82(s, 1H), 4.23 (t, J=6.2 Hz,2H),3.97(dd, J= 11.1,3.4Hz,2H),3.47(td,J=11.9, 1.9 Hz, 2H),2.66(s,3H),1.93-1.29(m,23H),1.20(s,9H) and Second eluting diastereomer 72: (3.7mg, 6.54 umol, 17.21 % yield). LCMS (M+H)= 566.2 ;Retention time (10 mM NH4HCO3)= 1.545 min. lHNMR (400 MHz, MeOD)δ 8.26(d,J=2.7 Hz,1H),8.03 (s,1H),7.45(dd,J=8.6,2.9 Hz,1H),7.36(d,J=8.6Hz, 1H),5.83(s,1H),4.11(t,J=6.1Hz,2H),3.85 (dd,J=10.9,3.7Hz,2H),3.34(td, J= 11.9,2.0Hz,2H),2.52(s,3H),2.13-2.07(m,1H),1.98-1.16(m,23H),1.08(s,9H).\",\n          \"refs\": null\n      }\n  ]\n}\n```\n"
    },
    {
      "role": "human",
      "content": "\n# Input Text #\n100% B over 2 minutes, then a 1-minute hold at 100%B;Flow: 1.0 mL/min;Detection:\nUV at 220 nm.\n<scheme id=p12.i9>\n| id             | reactant      | condition   | product       |\n|:---------------|:--------------|:------------|:--------------|\n| page12.scheme0 | page_12.mol_0 |             | page_12.mol_1 |\n</scheme>\n<text id=p12.i10>\nTo a stirred solution of 2-methylpyridin-4-ol (8.0 g, 73 mmol)in dichloromethane\n(90 ml) and MeOH(11 ml) was added tert-butylamine (15.7 ml,148 mmol) and the\nmixture was cooled to 0 °C. Bromine (7.55 ml,147 mmol) was added dropwise over a 20\nminute period. The reaction mixture was stirred at rt for 2 hours. Then the resulting slurry\nwas filtered through a buchner funnel and the solid was washed with methanol (100 ml)\nand dried overnight to afford 3,5-dibromo-2-methylpyridin-4-ol (10g,37.5 mmol, 51.1%\nyield). LCMS Method 4:retention time = 0.704 min.; observed ion =267.8.lH NMR (500\nMHz,DMSO-d6)δ12.33(brs,1H),8.21(s,1H),2.40(s,3H).\n</text>\n\n**JSON Output:**\n"
    }
  ],
  "output": {
    "results": [
      {
        "compound_id": "",
        "iupac_name": "3,5-dibromo-2-methylpyridin-4-ol",
        "structure_id": "page_12.mol_1",
        "detail_ids": [
          "p12.i10"
        ],
        "detail": "To a stirred solution of 2-methylpyridin-4-ol (8.0 g, 73 mmol)in dichloromethane (90 ml) and MeOH(11 ml) was added tert-butylamine (15.7 ml,148 mmol) and the mixture was cooled to 0 °C. Bromine (7.55 ml,147 mmol) was added dropwise over a 20 minute period. The reaction mixture was stirred at rt for 2 hours. Then the resulting slurry was filtered through a buchner funnel and the solid was washed with methanol (100 ml) and dried overnight to afford 3,5-dibromo-2-methylpyridin-4-ol (10g,37.5 mmol, 51.1% yield). LCMS Method 4:retention time = 0.704 min.; observed ion =267.8.lH NMR (500 MHz,DMSO-d6)δ12.33(brs,1H),8.21(s,1H),2.40(s,3H).",
        "refs": null
      }
    ]
  },
  "predict_output": {
    "results": [
      {
        "compound_id": "",
        "iupac_name": "3,5-dibromo-2-methylpyridin-4-ol",
        "structure_id": "page_12.mol_1",
        "detail_ids": [
          "p12.i10"
        ],
        "detail": "To a stirred solution of 2-methylpyridin-4-ol (8.0 g, 73 mmol)in dichloromethane (90 ml) and MeOH(11 ml) was added tert-butylamine (15.7 ml,148 mmol) and the mixture was cooled to 0 °C. Bromine (7.55 ml,147 mmol) was added dropwise over a 20 minute period. The reaction mixture was stirred at rt for 2 hours. Then the resulting slurry was filtered through a buchner funnel and the solid was washed with methanol (100 ml) and dried overnight to afford 3,5-dibromo-2-methylpyridin-4-ol (10g,37.5 mmol, 51.1% yield). LCMS Method 4:retention time = 0.704 min.; observed ion =267.8.lH NMR (500 MHz,DMSO-d6)δ12.33(brs,1H),8.21(s,1H),2.40(s,3H).",
        "refs": null
      }
    ]
  },
  "llm_response": "```json\n{\n    \"results\": [\n        {\n            \"compound_id\": \"\",\n            \"iupac_name\": \"3,5-dibromo-2-methylpyridin-4-ol\",\n            \"structure_id\": \"page_12.mol_1\",\n            \"detail_ids\": [\n                \"p12.i10\"\n            ],\n            \"detail\": \"To a stirred solution of 2-methylpyridin-4-ol (8.0 g, 73 mmol)in dichloromethane (90 ml) and MeOH(11 ml) was added tert-butylamine (15.7 ml,148 mmol) and the mixture was cooled to 0 °C. Bromine (7.55 ml,147 mmol) was added dropwise over a 20 minute period. The reaction mixture was stirred at rt for 2 hours. Then the resulting slurry was filtered through a buchner funnel and the solid was washed with methanol (100 ml) and dried overnight to afford 3,5-dibromo-2-methylpyridin-4-ol (10g,37.5 mmol, 51.1% yield). LCMS Method 4:retention time = 0.704 min.; observed ion =267.8.lH NMR (500 MHz,DMSO-d6)δ12.33(brs,1H),8.21(s,1H),2.40(s,3H).\",\n            \"refs\": null\n        }\n    ]\n}\n```",
  "model": "PatentSynthesisRouteAgent_gpt-4",
  "status": "",
  "name": "",
  "header_name": ""
},
{
  "id": "page13.scheme0",
  "input": [
    {
      "role": "system",
      "content": "\nYou are a chemical synthesis extraction agent. Extract **each synthesis step** from chemical patent text, with no inference across steps. Preserve wording and IDs exactly.\n\n# Input\nPatent text is tagged as:\n- <text id=...> ... </text>\n- <mol id=...> ... </mol>\n- <table id=...> ... </table>\n- <scheme id=...> ... </scheme>\nTags are top-level, ordered, and IDs must not be changed.\n\n# Extraction Fields\n1. compound_id  \n   - Use explicit product labels (e.g., \"Compound 2\", \"Intermediate A\").  \n   - If only section title defines the final product, assign section title (only last step).  \n   - Otherwise \"\".\n2. iupac_name  \n   - Use if explicitly given; otherwise \"\". No inference.\n3. structure_id  \n   - Only link <mol> ID if it shows the **final product** of the whole Example/Section. Else \"\".\n4. detail_ids  \n   - List of <text id=...> blocks describing procedure (exclude pure analytical data).\n5. detail  \n   - Concatenated verbatim text of detail_ids. No paraphrasing.\n6. refs  \n   - Compound identifiers referenced as inputs. Use exact labels. If none, null.\n\n# Output Format\n```json\n{\n  \"results\": [\n    {\n      \"compound_id\": \"...\",\n      \"iupac_name\": \"...\",\n      \"structure_id\": \"...\",\n      \"detail_ids\": [\"...\"],\n      \"detail\": \"...\",\n      \"refs\": [...] or null\n    }\n  ]\n}\n```\n\n# Rules\n1. One record per step; split at \"Step\" or clear process transitions.\n2. Never merge steps.\n3. No cross-step inference.\n4. Use section title as compound_id only for the last product-forming step.\n5. Accept phrases like \"title compound\" only as reference, not as identifiers.\n\n# Restriction\n1. Retain all <sub> and <sup> tags and their contents exactly as in the source text.\n\n\n## fewshot\nInput:\n```\n<text id=p43.i5>\nExample 37\n</text>\n<mol id=p43.i6>\npage_43.mol_0\n</mol>\n<text id=p43.i7>\n(S)-2-tert-Butoxy-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-2,3'-\nbipyridin-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (50 mg,0.103\nmmol) in DMF (10 mL) was added K2CO3(14.29 mg,0.103 mmol) and 1-bromobutane\n(14.17 mg,0.103 mmol). Then, the mixture was stirred for 20 hours at 45 °℃ and diluted\nwith water and ethyl acetate (30 mL). Organic layer separated, washed with brine (20 mL),\ndried over Na2SO4 and concentrated to obtain a crude product, which was purified by silica\n</text>\n<text id=p44.i0>\ngel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford\nisopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-\n[2,3'-bipyridin]-5'-yl)acetate (43 mg, 0.080 mmol, 77% yield) as a yellow oil.LCMS(M+\nH)=540.2; Retention time (10 mM NH4HCO3)=2.758.\n</text>\n<text id=p44.i1>\nStep 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (52 mg, 0.096 mmol) in\nmethanol (10 mL) and water (2 mL) was added sodium hydroxide (11.56 mg, 0.289 mmol)\nand stirred for 20 hours at 100°C.The mixture was concentrated under vacuo, diluted with\nHCl (1N,0.5 ml), extracted with ethyl acetate (5 ml) and concentrated to give crude\nproduct. The crude product was purified by Prep-HPLC {Instrument Gilson 281 (PHG-\n009); Column Xtimate Prep C18 OBD,21.2 x 250 mm,10 um; Mobile Phase A:water (10\nmM NH4HCO3); B:MeCN; Gradient 40-68%B in 8.0 min,stop at 13.0 min; Flow Rate\n(ml/min)30.00} togive (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-\nyl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetic acid (21.6 mg,0.042 mmol, 43.9 % yield) as\nwhite solid.LCMS(M+H)=498.1; Retention time(10 mM NH4HCO3)=1.716.lH\nNMR(400 MHz,MeOD)δ8.36(d,J=2.8Hz,1H), 8.17(s,1H), 7.56(dd, J=8.6,2.9 Hz,\n1H),7.47(d,J=8.6Hz,1H),5.82(s,1H),4.16(t,J=6.4Hz,2H),2.30-2.66(m,7H),\n1.91-1.77(m,2H),1.64-1.25(m,8H),1.21(s,9H),1.04(t,J=7.4Hz,3H),0.88-0.77\n(m, 6H).\n</text>\n<text id=p44.i4>\nExample 38\n</text>\n<mol id=p44.i5>\npage_44.mol_0\n</mol>\n<text id=p44.i6>\n(S)-2-tert-Butoxy-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-6'-methyl-2,3'-bipyridin-5'-yl)acetic acid\nStep 1: To a solution of 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethan-1-ol (250 mg,1.783\nmmol) and triethylamine (271 mg,2.68 mmol) in DCM (10 mL) was added methanesulfonyl\nchloride (225 mg, 1.962 mmol) at 0°℃. The mixture was stirred at rt for 1 h. The mixture\nwas taken up into aqueous Na2CO3 (20 mL) and extracted with DCM (10 ml X 3). The\n</text>\n<text id=p45.i0>\ncombined organic layers were washed with brine, dried over Na2SO4, concentrated to afford\n2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl methanesulfonate (300 mg, 1.100 mmol, 61.7 %\nyield) as oil which was used in the next step without further purification. LCMS: retention\ntime = 1.22 min, m/z = 219 [M+H]<sup>+</sup>, purity: 80% (214 nm).\n</text>\n<text id=p45.i1>\nStep 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (50 mg, 0.103\nmmol) in DMF (10 mL) was added K<sub>2</sub>CO<sub>3</sub> (71.4 mg, 0.517 mmol) and 2-(1,3-dimethyl-\n1H-pyrazol-4-yl)ethyl methanesulfonate (67.7 mg, 0.310 mmol). Then, the mixture was\nstirred for 20 hours at 45 °C and diluted with water and ethyl acetate (30 mL). Organic\nlayer separated, washed with brine (20 mL), dried over Na2SO<sub>4</sub> and concentrated to obtain\na crude product, which was purified by silica gel chromatography eluting with ethyl\nacetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (S)-2-(tert-butoxy)-2-(5-(2-\n(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-\nbipyridin]-5'-yl)acetate (41 mg, 0.068 mmol, 65.5 % yield) as a yellow oil. LCMS (M + H)\n= 606.2; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 2.234.\n</text>\n<text id=p45.i3>\nStep 3: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-\npyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-\nyl)acetate (41 mg, 0.068 mmol) in methanol (10 mL) and water (2 mL) was added sodium\nhydroxide (8.12 mg, 0.203 mmol) and stirred for 20 hours at 100 °C. The mixture was\nconcentrated under vacuo, diluted with HCl (1N, 0.5 ml), extracted with ethyl acetate (5\nml) and concentrated to give crude product. The crude product was purified by Prep-HPLC\n{Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2 x 250 mm, 10\num; Mobile Phase A: water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0\nmin, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (S)-2-(tert-butoxy)-2-(5-(2-(1,3-\ndimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-\nbipyridin]-5'-yl) acetic acid (17.3 mg, 0.031 mmol, 45.3 % yield) as white solid. LCMS (M\n+ H) = 564.2; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 1.452. <sup>1</sup>H NMR (400 MHz, MeOD) δ\n8.38 (d, J = 2.7 Hz, 1H), 8.16 (s, 1H), 7.56 (dd, J = 8.6, 2.9 Hz, 1H), 7.47 (d, J = 7.8 Hz,\n2H), 5.82 (s, 1H), 4.25 (t, J = 6.7 Hz, 2H), 3.80 (s, 3H), 3.23-2.57 (m, 9H), 2.25 (s, 3H),\n1.61-1.23 (m, 6H), 1.21 (s, 9H), 0.87- 0.74 (m, 6H).\n</text>\n```\nOutput:\n```json\n{\n    \"results\": [\n        {\n        \"compound_id\": \"Example 37.Step 1\",\n        \"iupac_name\": \"isopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate\",\n        \"structure_id\": \"\",\n        \"detail_ids\": [\n            \"p43.i7\",\n            \"p44.i0\"\n        ],\n        \"detail\": \"Step 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-methylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (50 mg,0.103 mmol) in DMF (10 mL) was added K2CO3(14.29 mg,0.103 mmol) and 1-bromobutane (14.17 mg,0.103 mmol). Then, the mixture was stirred for 20 hours at 45 °℃ and diluted with water and ethyl acetate (30 mL). Organic layer separated, washed with brine (20 mL), dried over Na2SO4 and concentrated to obtain a crude product, which was purified by silica\ngel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (43 mg, 0.080 mmol, 77% yield) as a yellow oil.LCMS(M+ H)=540.2; Retention time (10 mM NH4HCO3)=2.758.\",\n        \"refs\": null\n        },\n        {\n        \"compound_id\": \"Example 37.Step2\",\n        \"iupac_name\": \"(S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetic acid\",\n        \"structure_id\": \"page_43.mol_0\",\n        \"detail_ids\": [\n            \"p44.i1\"\n        ],\n        \"detail\": \"Step 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (52 mg, 0.096 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide (11.56 mg, 0.289 mmol) and stirred for 20 hours at 100°C.The mixture was concentrated under vacuo, diluted with HCl (1N,0.5 ml), extracted with ethyl acetate (5 ml) and concentrated to give crude product. The crude product was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD,21.2 x 250 mm,10 um; Mobile Phase A:water (10 mM NH4HCO3); B:MeCN; Gradient 40-68%B in 8.0 min,stop at 13.0 min; Flow Rate (ml/min)30.00} togive (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetic acid (21.6 mg,0.042 mmol, 43.9 % yield) as white solid.LCMS(M+H)=498.1; Retention time(10 mM NH4HCO3)=1.716.lH NMR(400 MHz,MeOD)δ8.36(d,J=2.8Hz,1H), 8.17(s,1H), 7.56(dd, J=8.6,2.9 Hz, 1H),7.47(d,J=8.6Hz,1H),5.82(s,1H),4.16(t,J=6.4Hz,2H),2.30-2.66(m,7H), 1.91-1.77(m,2H),1.64-1.25(m,8H),1.21(s,9H),1.04(t,J=7.4Hz,3H),0.88-0.77 (m, 6H).\",\n        \"refs\": null\n        },\n        {\n        \"compound_id\": \"Example 38.Step 1\",\n        \"iupac_name\": \"2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl methanesulfonate\",\n        \"structure_id\": \"\",\n        \"detail_ids\": [\n            \"p44.i6\",\n            \"p45.i0\"\n        ],\n        \"detail\": \"Step 1: To a solution of 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethan-1-ol (250 mg,1.783 mmol) and triethylamine (271 mg,2.68 mmol) in DCM (10 mL) was added methanesulfonyl chloride (225 mg, 1.962 mmol) at 0°℃. The mixture was stirred at rt for 1 h. The mixture was taken up into aqueous Na2CO3 (20 mL) and extracted with DCM (10 ml X 3). The\ncombined organic layers were washed with brine, dried over Na2SO4, concentrated to afford 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl methanesulfonate (300 mg, 1.100 mmol, 61.7 % yield) as oil which was used in the next step without further purification. LCMS: retention time = 1.22 min, m/z = 219 [M+H]<sup>+</sup>, purity: 80% (214 nm).\",\n        \"refs\": null\n        },\n        {\n        \"compound_id\": \"Example 38.Step 2\",\n        \"iupac_name\": \"isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate\",\n        \"structure_id\": \"\",\n        \"detail_ids\": [\n            \"p45.i1\"\n        ],\n        \"detail\": \"Step 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-methylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (50 mg, 0.103 mmol) in DMF (10 mL) was added K<sub>2</sub>CO<sub>3</sub> (71.4 mg, 0.517 mmol) and 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl methanesulfonate (67.7 mg, 0.310 mmol). Then, the mixture was stirred for 20 hours at 45 °C and diluted with water and ethyl acetate (30 mL). Organic layer separated, washed with brine (20 mL), dried over Na2SO<sub>4</sub> and concentrated to obtain a crude product, which was purified by silica gel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (41 mg, 0.068 mmol, 65.5 % yield) as a yellow oil. LCMS (M + H) = 606.2; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 2.234.\",\n        \"refs\": null\n        },\n        {\n        \"compound_id\": \"Example 38.Step 3\",\n        \"iupac_name\": \"(S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl) acetic acid\",\n        \"structure_id\": \"page_44.mol_0\",\n        \"detail_ids\": [\n            \"p45.i3\"\n        ],\n        \"detail\": \"Step 3: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (41 mg, 0.068 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide (8.12 mg, 0.203 mmol) and stirred for 20 hours at 100 °C. The mixture was concentrated under vacuo, diluted with HCl (1N, 0.5 ml), extracted with ethyl acetate (5 ml) and concentrated to give crude product. The crude product was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2 x 250 mm, 10 um; Mobile Phase A: water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl) acetic acid (17.3 mg, 0.031 mmol, 45.3 % yield) as white solid. LCMS (M + H) = 564.2; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 1.452. <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.38 (d, J = 2.7 Hz, 1H), 8.16 (s, 1H), 7.56 (dd, J = 8.6, 2.9 Hz, 1H), 7.47 (d, J = 7.8 Hz, 2H), 5.82 (s, 1H), 4.25 (t, J = 6.7 Hz, 2H), 3.80 (s, 3H), 3.23-2.57 (m, 9H), 2.25 (s, 3H), 1.61-1.23 (m, 6H), 1.21 (s, 9H), 0.87- 0.74 (m, 6H).\",\n        \"refs\": null\n        }\n    ]\n}\n```\n\n## fewshot\n1. refs is only used to record other compound identifiers explicitly referenced during the synthesis of this product (e.g., Example XX). If no such identifiers are mentioned, set refs: null.\nInput:\n```\n<scheme id=p12.i9>\n| id             | reactant      | condition   | product       |\n|:---------------|:--------------|:------------|:--------------|\n| page12.scheme0 | page_12.mol_0 |             | page_12.mol_1 |\n</scheme>\n<text id=p12.i10>\nTo a stirred solution of 2-methylpyridin-4-ol (8.0 g, 73 mmol)in dichloromethane\n(90 ml) and MeOH(11 ml) was added tert-butylamine (15.7 ml,148 mmol) and the\nmixture was cooled to 0 °C. Bromine (7.55 ml,147 mmol) was added dropwise over a 20\nminute period. The reaction mixture was stirred at rt for 2 hours. Then the resulting slurry\nwas filtered through a buchner funnel and the solid was washed with methanol (100 ml)\nand dried overnight to afford 3,5-dibromo-2-methylpyridin-4-ol (10g,37.5 mmol, 51.1%\nyield). LCMS Method 4:retention time = 0.704 min.; observed ion =267.8.lH NMR (500\nMHz,DMSO-d6)δ12.33(brs,1H),8.21(s,1H),2.40(s,3H).\n</text>\n```\nOutput:\n```json\n{\n    \"results\": [\n        {\n        \"compound_id\": \"\",\n        \"iupac_name\": \"3,5-dibromo-2-methylpyridin-4-ol\",\n        \"structure_id\": \"page_12.mol_1\",\n        \"detail_ids\": [\n            \"p12.i10\"\n        ],\n        \"detail\": \"To a stirred solution of 2-methylpyridin-4-ol (8.0 g, 73 mmol)in dichloromethane (90 ml) and MeOH(11 ml) was added tert-butylamine (15.7 ml,148 mmol) and the mixture was cooled to 0 °C. Bromine (7.55 ml,147 mmol) was added dropwise over a 20 minute period. The reaction mixture was stirred at rt for 2 hours. Then the resulting slurry was filtered through a buchner funnel and the solid was washed with methanol (100 ml) and dried overnight to afford 3,5-dibromo-2-methylpyridin-4-ol (10g,37.5 mmol, 51.1% yield). LCMS Method 4:retention time = 0.704 min.; observed ion =267.8.lH NMR (500 MHz,DMSO-d6)δ12.33(brs,1H),8.21(s,1H),2.40(s,3H).\",\n        \"refs\": null\n        }\n    ]\n}\n```\n\n## fewshot2\nThe current structure follows the following format:  \n1. First, this is an isomer example, with the Example Name shown at the top.  \n2. Under this Example, there are multiple Step blocks. Each step must use the top Example Name as the prefix in `compound_id`.  \n3. Each step corresponds to one product, so all steps must be separated into individual records.  \n4. The final step has associated structures. Both must be mapped back to the same Example Name, but output as separate records.  \nInput:\n```\n<text id=p75.i8>\nExample 65 and 66\n</text>\n<mol id=p76.i0>\npage_76.mol_0; page_76.mol_1\n</mol>\n<text id=p76.i1>\nFirst eluting isomer Second eluting isomer\n2S)-2-(tert-Butoxy)-2-(5-(cyclopropylmetl-xy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-\nyl)-[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate(50 mg,0.101 mmol)in\nDMF (10 mL) was added K2CO3 (41.8 mg, 0.303 mmol) and (bromomethyl)cyclopropane\n(27.2 mg,0.202 mmol). The mixture was stirred for 20 hours at 45°℃, diluted with water\nand ethyl acetate(30 mL),organic layer separated, washed with brine (20 mL),dried over\nNa2SO4 and concentrated to obtain a crude product which was purified by silica gel\nchromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1) to afford\nisopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (53 mg, 0.084 mmol, 84 %\nyield) as yellow oil. LCMS (M+H)=550.2; Retention time (10 mM NH4HCO3)=2.705\nmin.\n</text>\n<text id=p76.i5>\nStep 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-\n6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (52 mg,0.095\nmmol) in methanol (10 mL)and water (2 mL) was added sodium hydroxide (7.57 mg,\n0.189 mmol) and stirred for 20 hours at 100°C. The mixture was concentrated under\nvacuo, diluted with HCl (1N, 0.5 ml) and ethyl acetate (5ml). Organic layer separated and\nconcentrated to give crude product which was purified by Prep-HPLC {Instrument Gilson\n281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x250 mm, 10 um; Mobile Phase\nA: Water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0 min, stop at 13.0 min;\nFlow Rate (ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-\nmethyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (34.9 mg,\n0.069 mmol, 72.7% yield) as white solid.LCMS(M+H)=508.2; Retention time (10 mM\nNH4HCO3)=1.592 min.\n</text>\n<text id=p76.i7>\nStep 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-\nmethyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (32.1 mg,\n</text>\n<text id=p77.i0>\n0.063 mmol) were separated by SFC [Column AD-H 4.6x 100 mm; 5 um; Co-Solvent\nEtOH (1%ammonia/methanol)] to obtain\nFirst eluting diastereomer 65:(9.6 mg, 0.019 mmol,29.9% yield).LCMS(M+H)=\n508.2;Retention time (10 mM NH4HCO3) =1.605 min. lHNMR (400 MHz, MeOD) δ\n8.35(d,J=2.8Hz,1H),8.11 (s,1H), 7.54(dd,J=8.6,2.9 Hz, 1H), 7.45(d, J=8.6 Hz,\n1H),5.80(s,1H),4.00(d,J=7.0Hz,2H),2.66(s,3H),2.31-1.25(m,17H),1.18(s,9H),\n0.74-0.65(m,2H),0.50-0.34(m,2H)and\nSecond eluting diastereomer 66: (6.3 mg, 0.012 mmol, 19.63 % yield).LCMS (M+H)=\n508.0; Retention time (10 mM NH4HCO3) = 1.595 min. lH NMR (400 MHz, MeOD) δ\n8.23(d,J=2.7Hz,1H),7.98(s,1H),7.42(dd,J=8.6,2.8Hz,1H),7.33(d,J=8.6Hz,\n1H),5.78(s,1H),3.94-3.84(m,2H),2.52(s,3H),2.18-1.12(m,17H),1.07(s,9H),\n0.62-0.52(m,2H),0.31(q,J=4.6Hz,2H).\n</text>\n```\nOutput:\n```json\n{\n  \"results\": [\n      {\n          \"compound_id\": \"Example 65 and 66.Step 1\",\n          \"iupac_name\": \"isopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate\",\n          \"structure_id\": \"\",\n          \"detail_ids\": [\n              \"p76.i1\"\n          ],\n          \"detail\": \"Step 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate(50 mg,0.101 mmol)in DMF (10 mL) was added K2CO3 (41.8 mg, 0.303 mmol) and (bromomethyl)cyclopropane (27.2 mg,0.202 mmol). The mixture was stirred for 20 hours at 45°℃, diluted with water and ethyl acetate(30 mL),organic layer separated, washed with brine (20 mL),dried over Na2SO4 and concentrated to obtain a crude product which was purified by silica gel chromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1) to afford isopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (53 mg, 0.084 mmol, 84 % yield) as yellow oil. LCMS (M+H)=550.2; Retention time (10 mM NH4HCO3)=2.705 min.\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 65 and 66.Step 2\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"\",\n          \"detail_ids\": [\n              \"p76.i5\"\n          ],\n          \"detail\": \"Step 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (52 mg,0.095 mmol) in methanol (10 mL)and water (2 mL) was added sodium hydroxide (7.57 mg, 0.189 mmol) and stirred for 20 hours at 100°C. The mixture was concentrated under vacuo, diluted with HCl (1N, 0.5 ml) and ethyl acetate (5ml). Organic layer separated and concentrated to give crude product which was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x250 mm, 10 um; Mobile Phase A: Water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (34.9 mg, 0.069 mmol, 72.7% yield) as white solid.LCMS(M+H)=508.2; Retention time (10 mM NH4HCO3)=1.592 min.\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 65 and 66.Step 3\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"page_76.mol_0\",\n          \"detail_ids\": [\n              \"p76.i7\",\n              \"p77.i0\"\n          ],\n          \"detail\": \"Step 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (32.1 mg,\n0.063 mmol) were separated by SFC [Column AD-H 4.6x 100 mm; 5 um; Co-Solvent EtOH (1%ammonia/methanol)] to obtain\nFirst eluting diastereomer 65:(9.6 mg, 0.019 mmol,29.9% yield).LCMS(M+H)= 508.2;Retention time (10 mM NH4HCO3) =1.605 min. lHNMR (400 MHz, MeOD) δ 8.35(d,J=2.8Hz,1H),8.11 (s,1H), 7.54(dd,J=8.6,2.9 Hz, 1H), 7.45(d, J=8.6 Hz, 1H),5.80(s,1H),4.00(d,J=7.0Hz,2H),2.66(s,3H),2.31-1.25(m,17H),1.18(s,9H), 0.74-0.65(m,2H),0.50-0.34(m,2H)and Second eluting diastereomer 66: (6.3 mg, 0.012 mmol, 19.63 % yield).LCMS (M+H)= 508.0; Retention time (10 mM NH4HCO3) = 1.595 min. lH NMR (400 MHz, MeOD) δ 8.23(d,J=2.7Hz,1H),7.98(s,1H),7.42(dd,J=8.6,2.8Hz,1H),7.33(d,J=8.6Hz, 1H),5.78(s,1H),3.94-3.84(m,2H),2.52(s,3H),2.18-1.12(m,17H),1.07(s,9H), 0.62-0.52(m,2H),0.31(q,J=4.6Hz,2H).\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 65 and 66.Step 3\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"page_76.mol_1\",\n          \"detail_ids\": [\n              \"p76.i7\",\n              \"p77.i0\"\n          ],\n          \"detail\": \"Step 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (32.1 mg,\n0.063 mmol) were separated by SFC [Column AD-H 4.6x 100 mm; 5 um; Co-Solvent EtOH (1%ammonia/methanol)] to obtain\nFirst eluting diastereomer 65:(9.6 mg, 0.019 mmol,29.9% yield).LCMS(M+H)= 508.2;Retention time (10 mM NH4HCO3) =1.605 min. lHNMR (400 MHz, MeOD) δ 8.35(d,J=2.8Hz,1H),8.11 (s,1H), 7.54(dd,J=8.6,2.9 Hz, 1H), 7.45(d, J=8.6 Hz, 1H),5.80(s,1H),4.00(d,J=7.0Hz,2H),2.66(s,3H),2.31-1.25(m,17H),1.18(s,9H), 0.74-0.65(m,2H),0.50-0.34(m,2H)and Second eluting diastereomer 66: (6.3 mg, 0.012 mmol, 19.63 % yield).LCMS (M+H)= 508.0; Retention time (10 mM NH4HCO3) = 1.595 min. lH NMR (400 MHz, MeOD) δ 8.23(d,J=2.7Hz,1H),7.98(s,1H),7.42(dd,J=8.6,2.8Hz,1H),7.33(d,J=8.6Hz, 1H),5.78(s,1H),3.94-3.84(m,2H),2.52(s,3H),2.18-1.12(m,17H),1.07(s,9H), 0.62-0.52(m,2H),0.31(q,J=4.6Hz,2H).\",\n          \"refs\": null\n      }\n  ]\n}\n```\n\n## fewshot3\nThe current structure follows the following format:  \n1. First, this is an isomer example, with the Example Name shown at the top.\n2. Two structure_id values appear sequentially within the <mol> tags.\n3. The final step is associated with two structures. Both must be mapped back to the same Example Name, but output as separate records.\nInput:\n```\n<text id=p81.i1>\nExample 71 and 72\n</text>\n<mol id=p81.i2>\npage_81.mol_0\n</mol>\n<text id=p81.i3>\nFirst eluting isomer\n(2S)-2-(tert-Butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-\npyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (50mg, 0.101 mmol)in (10\nmL) was added K2CO3 (41.8 mg, 0.303 mmol) and 2-(tetrahydro-2H-pyran-4-yl)ethyl\nmethanesulfonate (31.5 mg,0.151 mmol).The mixture was stirred for 20 hours at 45°℃,\ndiluted with water and ethyl acetate(30 mL), organic layer separated, washed with brine\n(20 mL), dried over Na2SO4 and concentrated to obtain a crude product which was purified\nby silica gel chromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1)\nto afford isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-\n(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate (52 mg,0.082 mmol,\n81% yield) as yellow oil. LCMS (M+H)=608.2; Retention time (10 mM NH4HCO3)=\n2.649 min.\n</text>\n<text id=p81.i8>\nStep 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-\n5'-yl)acetate (52 mg, 0.086 mmol) in methanol (10 mL) and water (2 mL) was added\nsodium hydroxide (10.27 mg,0.257 mmol) and stirred for 20 hours at 100°C.The mixture\nwas concentrated under vacuo, diluted with HCl (1N,0.5 ml) and ethyl acetate (5ml).\nOrganic layer separated and concentrated to give crude product which was purified by\n</text>\n<mol id=p81.i11>\npage_81.mol_1\n</mol>\n<text id=p81.i12>\nSecond eluting isomer\n</text>\n<text id=p82.i0>\nPrep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x\n250 mm,10 um;Mobile Phase A: Water(10 mM NH4HCO3);B: MeCN;Gradient 40-\n68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (2S)-2-(tert-\nbutoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-\nyl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (21.5 mg,0.038 mmol, 44.4% yield) as white\nsolid.LCMS (M+H)=566.2;Retention time(10 mM NH4HCO3)=1.560 min.\n</text>\n<text id=p82.i2>\nStep 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-\n5'-yl)acetic acid (21.5 mg, 0.038 mmol) were separated by SFC [Column IC (4.6 x 100\nmm; 5 um); Co-Solvent MeOH (0.2%ammonia/methano)] to obtain\nFirst eluting diastereomer 71:(4.5 mg, 7.70 umol, 20.27% yield).LCMS (M+H)=566.1;\nRetention time(10 mM NH4HCO3)=1.558 min.lHNMR(400 MHz,MeOD) 8 8.37(d,J\n=2.8Hz,1H),8.13(s,1H),7.57(dd,J=8.6,2.9Hz,1H),7.46(d,J=8.6Hz,1H),5.82(s,\n1H), 4.23 (t, J=6.2 Hz,2H),3.97(dd, J= 11.1,3.4Hz,2H),3.47(td,J=11.9, 1.9 Hz,\n2H),2.66(s,3H),1.93-1.29(m,23H),1.20(s,9H) and\nSecond eluting diastereomer 72: (3.7mg, 6.54 umol, 17.21 % yield). LCMS (M+H)=\n566.2 ;Retention time (10 mM NH4HCO3)= 1.545 min. lHNMR (400 MHz, MeOD)δ\n8.26(d,J=2.7 Hz,1H),8.03 (s,1H),7.45(dd,J=8.6,2.9 Hz,1H),7.36(d,J=8.6Hz,\n1H),5.83(s,1H),4.11(t,J=6.1Hz,2H),3.85 (dd,J=10.9,3.7Hz,2H),3.34(td, J=\n11.9,2.0Hz,2H),2.52(s,3H),2.13-2.07(m,1H),1.98-1.16(m,23H),1.08(s,9H).\n</text>\n```\nOutput:\n```json\n{\n  \"results\": [\n      {\n          \"compound_id\": \"Example 71 and 72.Step 1\",\n          \"iupac_name\": \"isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate\",\n          \"structure_id\": \"\",\n          \"detail_ids\": [\n              \"p81.i3\"\n          ],\n          \"detail\": \"Step 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (50mg, 0.101 mmol)in (10 mL) was added K2CO3 (41.8 mg, 0.303 mmol) and 2-(tetrahydro-2H-pyran-4-yl)ethyl methanesulfonate (31.5 mg,0.151 mmol).The mixture was stirred for 20 hours at 45°℃, diluted with water and ethyl acetate(30 mL), organic layer separated, washed with brine (20 mL), dried over Na2SO4 and concentrated to obtain a crude product which was purified by silica gel chromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1) to afford isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate (52 mg,0.082 mmol, 81% yield) as yellow oil. LCMS (M+H)=608.2; Retention time (10 mM NH4HCO3)= 2.649 min.\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 71 and 72.Step 2\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"\",\n          \"detail_ids\": [\n              \"p81.i8\",\n              \"p82.i0\"\n          ],\n          \"detail\": \"Step 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate (52 mg, 0.086 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide (10.27 mg,0.257 mmol) and stirred for 20 hours at 100°C.The mixture was concentrated under vacuo, diluted with HCl (1N,0.5 ml) and ethyl acetate (5ml). Organic layer separated and concentrated to give crude product which was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x 250 mm,10 um;Mobile Phase A: Water(10 mM NH4HCO3);B: MeCN;Gradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (21.5 mg,0.038 mmol, 44.4% yield) as white solid.LCMS (M+H)=566.2;Retention time(10 mM NH4HCO3)=1.560 min.\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 71 and 72.Step 3\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"page_81.mol_0\",\n          \"detail_ids\": [\n              \"p82.i2\"\n          ],\n          \"detail\": \"Step 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (21.5 mg, 0.038 mmol) were separated by SFC [Column IC (4.6 x 100 mm; 5 um); Co-Solvent MeOH (0.2%ammonia/methano)] to obtain First eluting diastereomer 71:(4.5 mg, 7.70 umol, 20.27% yield).LCMS (M+H)=566.1; Retention time(10 mM NH4HCO3)=1.558 min.lHNMR(400 MHz,MeOD) 8 8.37(d,J =2.8Hz,1H),8.13(s,1H),7.57(dd,J=8.6,2.9Hz,1H),7.46(d,J=8.6Hz,1H),5.82(s, 1H), 4.23 (t, J=6.2 Hz,2H),3.97(dd, J= 11.1,3.4Hz,2H),3.47(td,J=11.9, 1.9 Hz, 2H),2.66(s,3H),1.93-1.29(m,23H),1.20(s,9H) and Second eluting diastereomer 72: (3.7mg, 6.54 umol, 17.21 % yield). LCMS (M+H)= 566.2 ;Retention time (10 mM NH4HCO3)= 1.545 min. lHNMR (400 MHz, MeOD)δ 8.26(d,J=2.7 Hz,1H),8.03 (s,1H),7.45(dd,J=8.6,2.9 Hz,1H),7.36(d,J=8.6Hz, 1H),5.83(s,1H),4.11(t,J=6.1Hz,2H),3.85 (dd,J=10.9,3.7Hz,2H),3.34(td, J= 11.9,2.0Hz,2H),2.52(s,3H),2.13-2.07(m,1H),1.98-1.16(m,23H),1.08(s,9H).\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 71 and 72.Step 3\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"page_81.mol_1\",\n          \"detail_ids\": [\n              \"p82.i2\"\n          ],\n          \"detail\": \"Step 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (21.5 mg, 0.038 mmol) were separated by SFC [Column IC (4.6 x 100 mm; 5 um); Co-Solvent MeOH (0.2%ammonia/methano)] to obtain First eluting diastereomer 71:(4.5 mg, 7.70 umol, 20.27% yield).LCMS (M+H)=566.1; Retention time(10 mM NH4HCO3)=1.558 min.lHNMR(400 MHz,MeOD) 8 8.37(d,J =2.8Hz,1H),8.13(s,1H),7.57(dd,J=8.6,2.9Hz,1H),7.46(d,J=8.6Hz,1H),5.82(s, 1H), 4.23 (t, J=6.2 Hz,2H),3.97(dd, J= 11.1,3.4Hz,2H),3.47(td,J=11.9, 1.9 Hz, 2H),2.66(s,3H),1.93-1.29(m,23H),1.20(s,9H) and Second eluting diastereomer 72: (3.7mg, 6.54 umol, 17.21 % yield). LCMS (M+H)= 566.2 ;Retention time (10 mM NH4HCO3)= 1.545 min. lHNMR (400 MHz, MeOD)δ 8.26(d,J=2.7 Hz,1H),8.03 (s,1H),7.45(dd,J=8.6,2.9 Hz,1H),7.36(d,J=8.6Hz, 1H),5.83(s,1H),4.11(t,J=6.1Hz,2H),3.85 (dd,J=10.9,3.7Hz,2H),3.34(td, J= 11.9,2.0Hz,2H),2.52(s,3H),2.13-2.07(m,1H),1.98-1.16(m,23H),1.08(s,9H).\",\n          \"refs\": null\n      }\n  ]\n}\n```\n"
    },
    {
      "role": "human",
      "content": "\n# Input Text #\nyield). LCMS Method 4:retention time = 0.704 min.; observed ion =267.8.lH NMR (500\nMHz,DMSO-d6)δ12.33(brs,1H),8.21(s,1H),2.40(s,3H).\n<scheme id=p13.i0>\n| id             | reactant      | condition   | product       |\n|:---------------|:--------------|:------------|:--------------|\n| page13.scheme0 | page_13.mol_0 |             | page_13.mol_1 |\n</scheme>\n<text id=p13.i1>\nTo a solution of 3,5-dibromo-2-methylpyridin-4-ol (13.5 g, 50.6 mmol) in POCl3\n(13.7 ml,147 mmol) was added triethylamine (7.05 ml,50.6 mmol) at 0°℃ slowly over 30\nmin.After addition, the ice bath was removed and was stirred at 80℃ for 1 h. The reaction\nmixture was cooled to rt and slowly quenched by adding it to crushed ice. The resulting\nslurry was diluted with DCM (250 mL) and slowly neutralized with 2M Na2CO3 solution.\nOnce neutralized the layers were separated and the organic layer was dried (Na2SO4),\nfiltered and concentrated to give 3,5-dibromo-4-chloro-2-methylpyridine (14 g,49 mmol,\n97% yield) as a off white solid.LCMS Method 4:retention time =1.47 min.;observed ion\n=285.7. lH NMR (500 MHz, CHLOROFORM-d) δ 8.56 (s, 1H), 2.72 (s, 3H).\n</text>\n\n**JSON Output:**\n"
    }
  ],
  "output": {
    "results": [
      {
        "compound_id": "",
        "iupac_name": "3,5-dibromo-4-chloro-2-methylpyridine",
        "structure_id": "page_13.mol_1",
        "detail_ids": [
          "p13.i1"
        ],
        "detail": "To a solution of 3,5-dibromo-2-methylpyridin-4-ol (13.5 g, 50.6 mmol) in POCl3 (13.7 ml,147 mmol) was added triethylamine (7.05 ml,50.6 mmol) at 0°℃ slowly over 30 min.After addition, the ice bath was removed and was stirred at 80℃ for 1 h. The reaction mixture was cooled to rt and slowly quenched by adding it to crushed ice. The resulting slurry was diluted with DCM (250 mL) and slowly neutralized with 2M Na2CO3 solution. Once neutralized the layers were separated and the organic layer was dried (Na2SO4), filtered and concentrated to give 3,5-dibromo-4-chloro-2-methylpyridine (14 g,49 mmol, 97% yield) as a off white solid.LCMS Method 4:retention time =1.47 min.;observed ion =285.7. lH NMR (500 MHz, CHLOROFORM-d) δ 8.56 (s, 1H), 2.72 (s, 3H).",
        "refs": null
      }
    ]
  },
  "predict_output": {
    "results": [
      {
        "compound_id": "",
        "iupac_name": "3,5-dibromo-4-chloro-2-methylpyridine",
        "structure_id": "page_13.mol_1",
        "detail_ids": [
          "p13.i1"
        ],
        "detail": "To a solution of 3,5-dibromo-2-methylpyridin-4-ol (13.5 g, 50.6 mmol) in POCl3 (13.7 ml,147 mmol) was added triethylamine (7.05 ml,50.6 mmol) at 0°℃ slowly over 30 min.After addition, the ice bath was removed and was stirred at 80℃ for 1 h. The reaction mixture was cooled to rt and slowly quenched by adding it to crushed ice. The resulting slurry was diluted with DCM (250 mL) and slowly neutralized with 2M Na2CO3 solution. Once neutralized the layers were separated and the organic layer was dried (Na2SO4), filtered and concentrated to give 3,5-dibromo-4-chloro-2-methylpyridine (14 g,49 mmol, 97% yield) as a off white solid.LCMS Method 4:retention time =1.47 min.;observed ion =285.7. lH NMR (500 MHz, CHLOROFORM-d) δ 8.56 (s, 1H), 2.72 (s, 3H).",
        "refs": null
      }
    ]
  },
  "llm_response": "```json\n{\n    \"results\": [\n        {\n            \"compound_id\": \"\",\n            \"iupac_name\": \"3,5-dibromo-4-chloro-2-methylpyridine\",\n            \"structure_id\": \"page_13.mol_1\",\n            \"detail_ids\": [\n                \"p13.i1\"\n            ],\n            \"detail\": \"To a solution of 3,5-dibromo-2-methylpyridin-4-ol (13.5 g, 50.6 mmol) in POCl3 (13.7 ml,147 mmol) was added triethylamine (7.05 ml,50.6 mmol) at 0°℃ slowly over 30 min.After addition, the ice bath was removed and was stirred at 80℃ for 1 h. The reaction mixture was cooled to rt and slowly quenched by adding it to crushed ice. The resulting slurry was diluted with DCM (250 mL) and slowly neutralized with 2M Na2CO3 solution. Once neutralized the layers were separated and the organic layer was dried (Na2SO4), filtered and concentrated to give 3,5-dibromo-4-chloro-2-methylpyridine (14 g,49 mmol, 97% yield) as a off white solid.LCMS Method 4:retention time =1.47 min.;observed ion =285.7. lH NMR (500 MHz, CHLOROFORM-d) δ 8.56 (s, 1H), 2.72 (s, 3H).\",\n            \"refs\": null\n        }\n    ]\n}\n```",
  "model": "PatentSynthesisRouteAgent_gpt-4",
  "status": "",
  "name": "",
  "header_name": ""
},
{
  "id": "page13.scheme1",
  "input": [
    {
      "role": "system",
      "content": "\nYou are a chemical synthesis extraction agent. Extract **each synthesis step** from chemical patent text, with no inference across steps. Preserve wording and IDs exactly.\n\n# Input\nPatent text is tagged as:\n- <text id=...> ... </text>\n- <mol id=...> ... </mol>\n- <table id=...> ... </table>\n- <scheme id=...> ... </scheme>\nTags are top-level, ordered, and IDs must not be changed.\n\n# Extraction Fields\n1. compound_id  \n   - Use explicit product labels (e.g., \"Compound 2\", \"Intermediate A\").  \n   - If only section title defines the final product, assign section title (only last step).  \n   - Otherwise \"\".\n2. iupac_name  \n   - Use if explicitly given; otherwise \"\". No inference.\n3. structure_id  \n   - Only link <mol> ID if it shows the **final product** of the whole Example/Section. Else \"\".\n4. detail_ids  \n   - List of <text id=...> blocks describing procedure (exclude pure analytical data).\n5. detail  \n   - Concatenated verbatim text of detail_ids. No paraphrasing.\n6. refs  \n   - Compound identifiers referenced as inputs. Use exact labels. If none, null.\n\n# Output Format\n```json\n{\n  \"results\": [\n    {\n      \"compound_id\": \"...\",\n      \"iupac_name\": \"...\",\n      \"structure_id\": \"...\",\n      \"detail_ids\": [\"...\"],\n      \"detail\": \"...\",\n      \"refs\": [...] or null\n    }\n  ]\n}\n```\n\n# Rules\n1. One record per step; split at \"Step\" or clear process transitions.\n2. Never merge steps.\n3. No cross-step inference.\n4. Use section title as compound_id only for the last product-forming step.\n5. Accept phrases like \"title compound\" only as reference, not as identifiers.\n\n# Restriction\n1. Retain all <sub> and <sup> tags and their contents exactly as in the source text.\n\n\n## fewshot\nInput:\n```\n<text id=p43.i5>\nExample 37\n</text>\n<mol id=p43.i6>\npage_43.mol_0\n</mol>\n<text id=p43.i7>\n(S)-2-tert-Butoxy-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-2,3'-\nbipyridin-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (50 mg,0.103\nmmol) in DMF (10 mL) was added K2CO3(14.29 mg,0.103 mmol) and 1-bromobutane\n(14.17 mg,0.103 mmol). Then, the mixture was stirred for 20 hours at 45 °℃ and diluted\nwith water and ethyl acetate (30 mL). Organic layer separated, washed with brine (20 mL),\ndried over Na2SO4 and concentrated to obtain a crude product, which was purified by silica\n</text>\n<text id=p44.i0>\ngel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford\nisopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-\n[2,3'-bipyridin]-5'-yl)acetate (43 mg, 0.080 mmol, 77% yield) as a yellow oil.LCMS(M+\nH)=540.2; Retention time (10 mM NH4HCO3)=2.758.\n</text>\n<text id=p44.i1>\nStep 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (52 mg, 0.096 mmol) in\nmethanol (10 mL) and water (2 mL) was added sodium hydroxide (11.56 mg, 0.289 mmol)\nand stirred for 20 hours at 100°C.The mixture was concentrated under vacuo, diluted with\nHCl (1N,0.5 ml), extracted with ethyl acetate (5 ml) and concentrated to give crude\nproduct. The crude product was purified by Prep-HPLC {Instrument Gilson 281 (PHG-\n009); Column Xtimate Prep C18 OBD,21.2 x 250 mm,10 um; Mobile Phase A:water (10\nmM NH4HCO3); B:MeCN; Gradient 40-68%B in 8.0 min,stop at 13.0 min; Flow Rate\n(ml/min)30.00} togive (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-\nyl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetic acid (21.6 mg,0.042 mmol, 43.9 % yield) as\nwhite solid.LCMS(M+H)=498.1; Retention time(10 mM NH4HCO3)=1.716.lH\nNMR(400 MHz,MeOD)δ8.36(d,J=2.8Hz,1H), 8.17(s,1H), 7.56(dd, J=8.6,2.9 Hz,\n1H),7.47(d,J=8.6Hz,1H),5.82(s,1H),4.16(t,J=6.4Hz,2H),2.30-2.66(m,7H),\n1.91-1.77(m,2H),1.64-1.25(m,8H),1.21(s,9H),1.04(t,J=7.4Hz,3H),0.88-0.77\n(m, 6H).\n</text>\n<text id=p44.i4>\nExample 38\n</text>\n<mol id=p44.i5>\npage_44.mol_0\n</mol>\n<text id=p44.i6>\n(S)-2-tert-Butoxy-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-6'-methyl-2,3'-bipyridin-5'-yl)acetic acid\nStep 1: To a solution of 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethan-1-ol (250 mg,1.783\nmmol) and triethylamine (271 mg,2.68 mmol) in DCM (10 mL) was added methanesulfonyl\nchloride (225 mg, 1.962 mmol) at 0°℃. The mixture was stirred at rt for 1 h. The mixture\nwas taken up into aqueous Na2CO3 (20 mL) and extracted with DCM (10 ml X 3). The\n</text>\n<text id=p45.i0>\ncombined organic layers were washed with brine, dried over Na2SO4, concentrated to afford\n2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl methanesulfonate (300 mg, 1.100 mmol, 61.7 %\nyield) as oil which was used in the next step without further purification. LCMS: retention\ntime = 1.22 min, m/z = 219 [M+H]<sup>+</sup>, purity: 80% (214 nm).\n</text>\n<text id=p45.i1>\nStep 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (50 mg, 0.103\nmmol) in DMF (10 mL) was added K<sub>2</sub>CO<sub>3</sub> (71.4 mg, 0.517 mmol) and 2-(1,3-dimethyl-\n1H-pyrazol-4-yl)ethyl methanesulfonate (67.7 mg, 0.310 mmol). Then, the mixture was\nstirred for 20 hours at 45 °C and diluted with water and ethyl acetate (30 mL). Organic\nlayer separated, washed with brine (20 mL), dried over Na2SO<sub>4</sub> and concentrated to obtain\na crude product, which was purified by silica gel chromatography eluting with ethyl\nacetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (S)-2-(tert-butoxy)-2-(5-(2-\n(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-\nbipyridin]-5'-yl)acetate (41 mg, 0.068 mmol, 65.5 % yield) as a yellow oil. LCMS (M + H)\n= 606.2; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 2.234.\n</text>\n<text id=p45.i3>\nStep 3: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-\npyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-\nyl)acetate (41 mg, 0.068 mmol) in methanol (10 mL) and water (2 mL) was added sodium\nhydroxide (8.12 mg, 0.203 mmol) and stirred for 20 hours at 100 °C. The mixture was\nconcentrated under vacuo, diluted with HCl (1N, 0.5 ml), extracted with ethyl acetate (5\nml) and concentrated to give crude product. The crude product was purified by Prep-HPLC\n{Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2 x 250 mm, 10\num; Mobile Phase A: water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0\nmin, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (S)-2-(tert-butoxy)-2-(5-(2-(1,3-\ndimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-\nbipyridin]-5'-yl) acetic acid (17.3 mg, 0.031 mmol, 45.3 % yield) as white solid. LCMS (M\n+ H) = 564.2; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 1.452. <sup>1</sup>H NMR (400 MHz, MeOD) δ\n8.38 (d, J = 2.7 Hz, 1H), 8.16 (s, 1H), 7.56 (dd, J = 8.6, 2.9 Hz, 1H), 7.47 (d, J = 7.8 Hz,\n2H), 5.82 (s, 1H), 4.25 (t, J = 6.7 Hz, 2H), 3.80 (s, 3H), 3.23-2.57 (m, 9H), 2.25 (s, 3H),\n1.61-1.23 (m, 6H), 1.21 (s, 9H), 0.87- 0.74 (m, 6H).\n</text>\n```\nOutput:\n```json\n{\n    \"results\": [\n        {\n        \"compound_id\": \"Example 37.Step 1\",\n        \"iupac_name\": \"isopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate\",\n        \"structure_id\": \"\",\n        \"detail_ids\": [\n            \"p43.i7\",\n            \"p44.i0\"\n        ],\n        \"detail\": \"Step 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-methylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (50 mg,0.103 mmol) in DMF (10 mL) was added K2CO3(14.29 mg,0.103 mmol) and 1-bromobutane (14.17 mg,0.103 mmol). Then, the mixture was stirred for 20 hours at 45 °℃ and diluted with water and ethyl acetate (30 mL). Organic layer separated, washed with brine (20 mL), dried over Na2SO4 and concentrated to obtain a crude product, which was purified by silica\ngel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (43 mg, 0.080 mmol, 77% yield) as a yellow oil.LCMS(M+ H)=540.2; Retention time (10 mM NH4HCO3)=2.758.\",\n        \"refs\": null\n        },\n        {\n        \"compound_id\": \"Example 37.Step2\",\n        \"iupac_name\": \"(S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetic acid\",\n        \"structure_id\": \"page_43.mol_0\",\n        \"detail_ids\": [\n            \"p44.i1\"\n        ],\n        \"detail\": \"Step 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (52 mg, 0.096 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide (11.56 mg, 0.289 mmol) and stirred for 20 hours at 100°C.The mixture was concentrated under vacuo, diluted with HCl (1N,0.5 ml), extracted with ethyl acetate (5 ml) and concentrated to give crude product. The crude product was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD,21.2 x 250 mm,10 um; Mobile Phase A:water (10 mM NH4HCO3); B:MeCN; Gradient 40-68%B in 8.0 min,stop at 13.0 min; Flow Rate (ml/min)30.00} togive (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetic acid (21.6 mg,0.042 mmol, 43.9 % yield) as white solid.LCMS(M+H)=498.1; Retention time(10 mM NH4HCO3)=1.716.lH NMR(400 MHz,MeOD)δ8.36(d,J=2.8Hz,1H), 8.17(s,1H), 7.56(dd, J=8.6,2.9 Hz, 1H),7.47(d,J=8.6Hz,1H),5.82(s,1H),4.16(t,J=6.4Hz,2H),2.30-2.66(m,7H), 1.91-1.77(m,2H),1.64-1.25(m,8H),1.21(s,9H),1.04(t,J=7.4Hz,3H),0.88-0.77 (m, 6H).\",\n        \"refs\": null\n        },\n        {\n        \"compound_id\": \"Example 38.Step 1\",\n        \"iupac_name\": \"2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl methanesulfonate\",\n        \"structure_id\": \"\",\n        \"detail_ids\": [\n            \"p44.i6\",\n            \"p45.i0\"\n        ],\n        \"detail\": \"Step 1: To a solution of 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethan-1-ol (250 mg,1.783 mmol) and triethylamine (271 mg,2.68 mmol) in DCM (10 mL) was added methanesulfonyl chloride (225 mg, 1.962 mmol) at 0°℃. The mixture was stirred at rt for 1 h. The mixture was taken up into aqueous Na2CO3 (20 mL) and extracted with DCM (10 ml X 3). The\ncombined organic layers were washed with brine, dried over Na2SO4, concentrated to afford 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl methanesulfonate (300 mg, 1.100 mmol, 61.7 % yield) as oil which was used in the next step without further purification. LCMS: retention time = 1.22 min, m/z = 219 [M+H]<sup>+</sup>, purity: 80% (214 nm).\",\n        \"refs\": null\n        },\n        {\n        \"compound_id\": \"Example 38.Step 2\",\n        \"iupac_name\": \"isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate\",\n        \"structure_id\": \"\",\n        \"detail_ids\": [\n            \"p45.i1\"\n        ],\n        \"detail\": \"Step 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-methylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (50 mg, 0.103 mmol) in DMF (10 mL) was added K<sub>2</sub>CO<sub>3</sub> (71.4 mg, 0.517 mmol) and 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl methanesulfonate (67.7 mg, 0.310 mmol). Then, the mixture was stirred for 20 hours at 45 °C and diluted with water and ethyl acetate (30 mL). Organic layer separated, washed with brine (20 mL), dried over Na2SO<sub>4</sub> and concentrated to obtain a crude product, which was purified by silica gel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (41 mg, 0.068 mmol, 65.5 % yield) as a yellow oil. LCMS (M + H) = 606.2; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 2.234.\",\n        \"refs\": null\n        },\n        {\n        \"compound_id\": \"Example 38.Step 3\",\n        \"iupac_name\": \"(S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl) acetic acid\",\n        \"structure_id\": \"page_44.mol_0\",\n        \"detail_ids\": [\n            \"p45.i3\"\n        ],\n        \"detail\": \"Step 3: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (41 mg, 0.068 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide (8.12 mg, 0.203 mmol) and stirred for 20 hours at 100 °C. The mixture was concentrated under vacuo, diluted with HCl (1N, 0.5 ml), extracted with ethyl acetate (5 ml) and concentrated to give crude product. The crude product was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2 x 250 mm, 10 um; Mobile Phase A: water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl) acetic acid (17.3 mg, 0.031 mmol, 45.3 % yield) as white solid. LCMS (M + H) = 564.2; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 1.452. <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.38 (d, J = 2.7 Hz, 1H), 8.16 (s, 1H), 7.56 (dd, J = 8.6, 2.9 Hz, 1H), 7.47 (d, J = 7.8 Hz, 2H), 5.82 (s, 1H), 4.25 (t, J = 6.7 Hz, 2H), 3.80 (s, 3H), 3.23-2.57 (m, 9H), 2.25 (s, 3H), 1.61-1.23 (m, 6H), 1.21 (s, 9H), 0.87- 0.74 (m, 6H).\",\n        \"refs\": null\n        }\n    ]\n}\n```\n\n## fewshot\n1. refs is only used to record other compound identifiers explicitly referenced during the synthesis of this product (e.g., Example XX). If no such identifiers are mentioned, set refs: null.\nInput:\n```\n<scheme id=p12.i9>\n| id             | reactant      | condition   | product       |\n|:---------------|:--------------|:------------|:--------------|\n| page12.scheme0 | page_12.mol_0 |             | page_12.mol_1 |\n</scheme>\n<text id=p12.i10>\nTo a stirred solution of 2-methylpyridin-4-ol (8.0 g, 73 mmol)in dichloromethane\n(90 ml) and MeOH(11 ml) was added tert-butylamine (15.7 ml,148 mmol) and the\nmixture was cooled to 0 °C. Bromine (7.55 ml,147 mmol) was added dropwise over a 20\nminute period. The reaction mixture was stirred at rt for 2 hours. Then the resulting slurry\nwas filtered through a buchner funnel and the solid was washed with methanol (100 ml)\nand dried overnight to afford 3,5-dibromo-2-methylpyridin-4-ol (10g,37.5 mmol, 51.1%\nyield). LCMS Method 4:retention time = 0.704 min.; observed ion =267.8.lH NMR (500\nMHz,DMSO-d6)δ12.33(brs,1H),8.21(s,1H),2.40(s,3H).\n</text>\n```\nOutput:\n```json\n{\n    \"results\": [\n        {\n        \"compound_id\": \"\",\n        \"iupac_name\": \"3,5-dibromo-2-methylpyridin-4-ol\",\n        \"structure_id\": \"page_12.mol_1\",\n        \"detail_ids\": [\n            \"p12.i10\"\n        ],\n        \"detail\": \"To a stirred solution of 2-methylpyridin-4-ol (8.0 g, 73 mmol)in dichloromethane (90 ml) and MeOH(11 ml) was added tert-butylamine (15.7 ml,148 mmol) and the mixture was cooled to 0 °C. Bromine (7.55 ml,147 mmol) was added dropwise over a 20 minute period. The reaction mixture was stirred at rt for 2 hours. Then the resulting slurry was filtered through a buchner funnel and the solid was washed with methanol (100 ml) and dried overnight to afford 3,5-dibromo-2-methylpyridin-4-ol (10g,37.5 mmol, 51.1% yield). LCMS Method 4:retention time = 0.704 min.; observed ion =267.8.lH NMR (500 MHz,DMSO-d6)δ12.33(brs,1H),8.21(s,1H),2.40(s,3H).\",\n        \"refs\": null\n        }\n    ]\n}\n```\n\n## fewshot2\nThe current structure follows the following format:  \n1. First, this is an isomer example, with the Example Name shown at the top.  \n2. Under this Example, there are multiple Step blocks. Each step must use the top Example Name as the prefix in `compound_id`.  \n3. Each step corresponds to one product, so all steps must be separated into individual records.  \n4. The final step has associated structures. Both must be mapped back to the same Example Name, but output as separate records.  \nInput:\n```\n<text id=p75.i8>\nExample 65 and 66\n</text>\n<mol id=p76.i0>\npage_76.mol_0; page_76.mol_1\n</mol>\n<text id=p76.i1>\nFirst eluting isomer Second eluting isomer\n2S)-2-(tert-Butoxy)-2-(5-(cyclopropylmetl-xy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-\nyl)-[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate(50 mg,0.101 mmol)in\nDMF (10 mL) was added K2CO3 (41.8 mg, 0.303 mmol) and (bromomethyl)cyclopropane\n(27.2 mg,0.202 mmol). The mixture was stirred for 20 hours at 45°℃, diluted with water\nand ethyl acetate(30 mL),organic layer separated, washed with brine (20 mL),dried over\nNa2SO4 and concentrated to obtain a crude product which was purified by silica gel\nchromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1) to afford\nisopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (53 mg, 0.084 mmol, 84 %\nyield) as yellow oil. LCMS (M+H)=550.2; Retention time (10 mM NH4HCO3)=2.705\nmin.\n</text>\n<text id=p76.i5>\nStep 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-\n6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (52 mg,0.095\nmmol) in methanol (10 mL)and water (2 mL) was added sodium hydroxide (7.57 mg,\n0.189 mmol) and stirred for 20 hours at 100°C. The mixture was concentrated under\nvacuo, diluted with HCl (1N, 0.5 ml) and ethyl acetate (5ml). Organic layer separated and\nconcentrated to give crude product which was purified by Prep-HPLC {Instrument Gilson\n281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x250 mm, 10 um; Mobile Phase\nA: Water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0 min, stop at 13.0 min;\nFlow Rate (ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-\nmethyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (34.9 mg,\n0.069 mmol, 72.7% yield) as white solid.LCMS(M+H)=508.2; Retention time (10 mM\nNH4HCO3)=1.592 min.\n</text>\n<text id=p76.i7>\nStep 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-\nmethyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (32.1 mg,\n</text>\n<text id=p77.i0>\n0.063 mmol) were separated by SFC [Column AD-H 4.6x 100 mm; 5 um; Co-Solvent\nEtOH (1%ammonia/methanol)] to obtain\nFirst eluting diastereomer 65:(9.6 mg, 0.019 mmol,29.9% yield).LCMS(M+H)=\n508.2;Retention time (10 mM NH4HCO3) =1.605 min. lHNMR (400 MHz, MeOD) δ\n8.35(d,J=2.8Hz,1H),8.11 (s,1H), 7.54(dd,J=8.6,2.9 Hz, 1H), 7.45(d, J=8.6 Hz,\n1H),5.80(s,1H),4.00(d,J=7.0Hz,2H),2.66(s,3H),2.31-1.25(m,17H),1.18(s,9H),\n0.74-0.65(m,2H),0.50-0.34(m,2H)and\nSecond eluting diastereomer 66: (6.3 mg, 0.012 mmol, 19.63 % yield).LCMS (M+H)=\n508.0; Retention time (10 mM NH4HCO3) = 1.595 min. lH NMR (400 MHz, MeOD) δ\n8.23(d,J=2.7Hz,1H),7.98(s,1H),7.42(dd,J=8.6,2.8Hz,1H),7.33(d,J=8.6Hz,\n1H),5.78(s,1H),3.94-3.84(m,2H),2.52(s,3H),2.18-1.12(m,17H),1.07(s,9H),\n0.62-0.52(m,2H),0.31(q,J=4.6Hz,2H).\n</text>\n```\nOutput:\n```json\n{\n  \"results\": [\n      {\n          \"compound_id\": \"Example 65 and 66.Step 1\",\n          \"iupac_name\": \"isopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate\",\n          \"structure_id\": \"\",\n          \"detail_ids\": [\n              \"p76.i1\"\n          ],\n          \"detail\": \"Step 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate(50 mg,0.101 mmol)in DMF (10 mL) was added K2CO3 (41.8 mg, 0.303 mmol) and (bromomethyl)cyclopropane (27.2 mg,0.202 mmol). The mixture was stirred for 20 hours at 45°℃, diluted with water and ethyl acetate(30 mL),organic layer separated, washed with brine (20 mL),dried over Na2SO4 and concentrated to obtain a crude product which was purified by silica gel chromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1) to afford isopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (53 mg, 0.084 mmol, 84 % yield) as yellow oil. LCMS (M+H)=550.2; Retention time (10 mM NH4HCO3)=2.705 min.\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 65 and 66.Step 2\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"\",\n          \"detail_ids\": [\n              \"p76.i5\"\n          ],\n          \"detail\": \"Step 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (52 mg,0.095 mmol) in methanol (10 mL)and water (2 mL) was added sodium hydroxide (7.57 mg, 0.189 mmol) and stirred for 20 hours at 100°C. The mixture was concentrated under vacuo, diluted with HCl (1N, 0.5 ml) and ethyl acetate (5ml). Organic layer separated and concentrated to give crude product which was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x250 mm, 10 um; Mobile Phase A: Water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (34.9 mg, 0.069 mmol, 72.7% yield) as white solid.LCMS(M+H)=508.2; Retention time (10 mM NH4HCO3)=1.592 min.\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 65 and 66.Step 3\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"page_76.mol_0\",\n          \"detail_ids\": [\n              \"p76.i7\",\n              \"p77.i0\"\n          ],\n          \"detail\": \"Step 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (32.1 mg,\n0.063 mmol) were separated by SFC [Column AD-H 4.6x 100 mm; 5 um; Co-Solvent EtOH (1%ammonia/methanol)] to obtain\nFirst eluting diastereomer 65:(9.6 mg, 0.019 mmol,29.9% yield).LCMS(M+H)= 508.2;Retention time (10 mM NH4HCO3) =1.605 min. lHNMR (400 MHz, MeOD) δ 8.35(d,J=2.8Hz,1H),8.11 (s,1H), 7.54(dd,J=8.6,2.9 Hz, 1H), 7.45(d, J=8.6 Hz, 1H),5.80(s,1H),4.00(d,J=7.0Hz,2H),2.66(s,3H),2.31-1.25(m,17H),1.18(s,9H), 0.74-0.65(m,2H),0.50-0.34(m,2H)and Second eluting diastereomer 66: (6.3 mg, 0.012 mmol, 19.63 % yield).LCMS (M+H)= 508.0; Retention time (10 mM NH4HCO3) = 1.595 min. lH NMR (400 MHz, MeOD) δ 8.23(d,J=2.7Hz,1H),7.98(s,1H),7.42(dd,J=8.6,2.8Hz,1H),7.33(d,J=8.6Hz, 1H),5.78(s,1H),3.94-3.84(m,2H),2.52(s,3H),2.18-1.12(m,17H),1.07(s,9H), 0.62-0.52(m,2H),0.31(q,J=4.6Hz,2H).\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 65 and 66.Step 3\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"page_76.mol_1\",\n          \"detail_ids\": [\n              \"p76.i7\",\n              \"p77.i0\"\n          ],\n          \"detail\": \"Step 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (32.1 mg,\n0.063 mmol) were separated by SFC [Column AD-H 4.6x 100 mm; 5 um; Co-Solvent EtOH (1%ammonia/methanol)] to obtain\nFirst eluting diastereomer 65:(9.6 mg, 0.019 mmol,29.9% yield).LCMS(M+H)= 508.2;Retention time (10 mM NH4HCO3) =1.605 min. lHNMR (400 MHz, MeOD) δ 8.35(d,J=2.8Hz,1H),8.11 (s,1H), 7.54(dd,J=8.6,2.9 Hz, 1H), 7.45(d, J=8.6 Hz, 1H),5.80(s,1H),4.00(d,J=7.0Hz,2H),2.66(s,3H),2.31-1.25(m,17H),1.18(s,9H), 0.74-0.65(m,2H),0.50-0.34(m,2H)and Second eluting diastereomer 66: (6.3 mg, 0.012 mmol, 19.63 % yield).LCMS (M+H)= 508.0; Retention time (10 mM NH4HCO3) = 1.595 min. lH NMR (400 MHz, MeOD) δ 8.23(d,J=2.7Hz,1H),7.98(s,1H),7.42(dd,J=8.6,2.8Hz,1H),7.33(d,J=8.6Hz, 1H),5.78(s,1H),3.94-3.84(m,2H),2.52(s,3H),2.18-1.12(m,17H),1.07(s,9H), 0.62-0.52(m,2H),0.31(q,J=4.6Hz,2H).\",\n          \"refs\": null\n      }\n  ]\n}\n```\n\n## fewshot3\nThe current structure follows the following format:  \n1. First, this is an isomer example, with the Example Name shown at the top.\n2. Two structure_id values appear sequentially within the <mol> tags.\n3. The final step is associated with two structures. Both must be mapped back to the same Example Name, but output as separate records.\nInput:\n```\n<text id=p81.i1>\nExample 71 and 72\n</text>\n<mol id=p81.i2>\npage_81.mol_0\n</mol>\n<text id=p81.i3>\nFirst eluting isomer\n(2S)-2-(tert-Butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-\npyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (50mg, 0.101 mmol)in (10\nmL) was added K2CO3 (41.8 mg, 0.303 mmol) and 2-(tetrahydro-2H-pyran-4-yl)ethyl\nmethanesulfonate (31.5 mg,0.151 mmol).The mixture was stirred for 20 hours at 45°℃,\ndiluted with water and ethyl acetate(30 mL), organic layer separated, washed with brine\n(20 mL), dried over Na2SO4 and concentrated to obtain a crude product which was purified\nby silica gel chromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1)\nto afford isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-\n(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate (52 mg,0.082 mmol,\n81% yield) as yellow oil. LCMS (M+H)=608.2; Retention time (10 mM NH4HCO3)=\n2.649 min.\n</text>\n<text id=p81.i8>\nStep 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-\n5'-yl)acetate (52 mg, 0.086 mmol) in methanol (10 mL) and water (2 mL) was added\nsodium hydroxide (10.27 mg,0.257 mmol) and stirred for 20 hours at 100°C.The mixture\nwas concentrated under vacuo, diluted with HCl (1N,0.5 ml) and ethyl acetate (5ml).\nOrganic layer separated and concentrated to give crude product which was purified by\n</text>\n<mol id=p81.i11>\npage_81.mol_1\n</mol>\n<text id=p81.i12>\nSecond eluting isomer\n</text>\n<text id=p82.i0>\nPrep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x\n250 mm,10 um;Mobile Phase A: Water(10 mM NH4HCO3);B: MeCN;Gradient 40-\n68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (2S)-2-(tert-\nbutoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-\nyl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (21.5 mg,0.038 mmol, 44.4% yield) as white\nsolid.LCMS (M+H)=566.2;Retention time(10 mM NH4HCO3)=1.560 min.\n</text>\n<text id=p82.i2>\nStep 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-\n5'-yl)acetic acid (21.5 mg, 0.038 mmol) were separated by SFC [Column IC (4.6 x 100\nmm; 5 um); Co-Solvent MeOH (0.2%ammonia/methano)] to obtain\nFirst eluting diastereomer 71:(4.5 mg, 7.70 umol, 20.27% yield).LCMS (M+H)=566.1;\nRetention time(10 mM NH4HCO3)=1.558 min.lHNMR(400 MHz,MeOD) 8 8.37(d,J\n=2.8Hz,1H),8.13(s,1H),7.57(dd,J=8.6,2.9Hz,1H),7.46(d,J=8.6Hz,1H),5.82(s,\n1H), 4.23 (t, J=6.2 Hz,2H),3.97(dd, J= 11.1,3.4Hz,2H),3.47(td,J=11.9, 1.9 Hz,\n2H),2.66(s,3H),1.93-1.29(m,23H),1.20(s,9H) and\nSecond eluting diastereomer 72: (3.7mg, 6.54 umol, 17.21 % yield). LCMS (M+H)=\n566.2 ;Retention time (10 mM NH4HCO3)= 1.545 min. lHNMR (400 MHz, MeOD)δ\n8.26(d,J=2.7 Hz,1H),8.03 (s,1H),7.45(dd,J=8.6,2.9 Hz,1H),7.36(d,J=8.6Hz,\n1H),5.83(s,1H),4.11(t,J=6.1Hz,2H),3.85 (dd,J=10.9,3.7Hz,2H),3.34(td, J=\n11.9,2.0Hz,2H),2.52(s,3H),2.13-2.07(m,1H),1.98-1.16(m,23H),1.08(s,9H).\n</text>\n```\nOutput:\n```json\n{\n  \"results\": [\n      {\n          \"compound_id\": \"Example 71 and 72.Step 1\",\n          \"iupac_name\": \"isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate\",\n          \"structure_id\": \"\",\n          \"detail_ids\": [\n              \"p81.i3\"\n          ],\n          \"detail\": \"Step 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (50mg, 0.101 mmol)in (10 mL) was added K2CO3 (41.8 mg, 0.303 mmol) and 2-(tetrahydro-2H-pyran-4-yl)ethyl methanesulfonate (31.5 mg,0.151 mmol).The mixture was stirred for 20 hours at 45°℃, diluted with water and ethyl acetate(30 mL), organic layer separated, washed with brine (20 mL), dried over Na2SO4 and concentrated to obtain a crude product which was purified by silica gel chromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1) to afford isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate (52 mg,0.082 mmol, 81% yield) as yellow oil. LCMS (M+H)=608.2; Retention time (10 mM NH4HCO3)= 2.649 min.\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 71 and 72.Step 2\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"\",\n          \"detail_ids\": [\n              \"p81.i8\",\n              \"p82.i0\"\n          ],\n          \"detail\": \"Step 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate (52 mg, 0.086 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide (10.27 mg,0.257 mmol) and stirred for 20 hours at 100°C.The mixture was concentrated under vacuo, diluted with HCl (1N,0.5 ml) and ethyl acetate (5ml). Organic layer separated and concentrated to give crude product which was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x 250 mm,10 um;Mobile Phase A: Water(10 mM NH4HCO3);B: MeCN;Gradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (21.5 mg,0.038 mmol, 44.4% yield) as white solid.LCMS (M+H)=566.2;Retention time(10 mM NH4HCO3)=1.560 min.\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 71 and 72.Step 3\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"page_81.mol_0\",\n          \"detail_ids\": [\n              \"p82.i2\"\n          ],\n          \"detail\": \"Step 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (21.5 mg, 0.038 mmol) were separated by SFC [Column IC (4.6 x 100 mm; 5 um); Co-Solvent MeOH (0.2%ammonia/methano)] to obtain First eluting diastereomer 71:(4.5 mg, 7.70 umol, 20.27% yield).LCMS (M+H)=566.1; Retention time(10 mM NH4HCO3)=1.558 min.lHNMR(400 MHz,MeOD) 8 8.37(d,J =2.8Hz,1H),8.13(s,1H),7.57(dd,J=8.6,2.9Hz,1H),7.46(d,J=8.6Hz,1H),5.82(s, 1H), 4.23 (t, J=6.2 Hz,2H),3.97(dd, J= 11.1,3.4Hz,2H),3.47(td,J=11.9, 1.9 Hz, 2H),2.66(s,3H),1.93-1.29(m,23H),1.20(s,9H) and Second eluting diastereomer 72: (3.7mg, 6.54 umol, 17.21 % yield). LCMS (M+H)= 566.2 ;Retention time (10 mM NH4HCO3)= 1.545 min. lHNMR (400 MHz, MeOD)δ 8.26(d,J=2.7 Hz,1H),8.03 (s,1H),7.45(dd,J=8.6,2.9 Hz,1H),7.36(d,J=8.6Hz, 1H),5.83(s,1H),4.11(t,J=6.1Hz,2H),3.85 (dd,J=10.9,3.7Hz,2H),3.34(td, J= 11.9,2.0Hz,2H),2.52(s,3H),2.13-2.07(m,1H),1.98-1.16(m,23H),1.08(s,9H).\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 71 and 72.Step 3\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"page_81.mol_1\",\n          \"detail_ids\": [\n              \"p82.i2\"\n          ],\n          \"detail\": \"Step 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (21.5 mg, 0.038 mmol) were separated by SFC [Column IC (4.6 x 100 mm; 5 um); Co-Solvent MeOH (0.2%ammonia/methano)] to obtain First eluting diastereomer 71:(4.5 mg, 7.70 umol, 20.27% yield).LCMS (M+H)=566.1; Retention time(10 mM NH4HCO3)=1.558 min.lHNMR(400 MHz,MeOD) 8 8.37(d,J =2.8Hz,1H),8.13(s,1H),7.57(dd,J=8.6,2.9Hz,1H),7.46(d,J=8.6Hz,1H),5.82(s, 1H), 4.23 (t, J=6.2 Hz,2H),3.97(dd, J= 11.1,3.4Hz,2H),3.47(td,J=11.9, 1.9 Hz, 2H),2.66(s,3H),1.93-1.29(m,23H),1.20(s,9H) and Second eluting diastereomer 72: (3.7mg, 6.54 umol, 17.21 % yield). LCMS (M+H)= 566.2 ;Retention time (10 mM NH4HCO3)= 1.545 min. lHNMR (400 MHz, MeOD)δ 8.26(d,J=2.7 Hz,1H),8.03 (s,1H),7.45(dd,J=8.6,2.9 Hz,1H),7.36(d,J=8.6Hz, 1H),5.83(s,1H),4.11(t,J=6.1Hz,2H),3.85 (dd,J=10.9,3.7Hz,2H),3.34(td, J= 11.9,2.0Hz,2H),2.52(s,3H),2.13-2.07(m,1H),1.98-1.16(m,23H),1.08(s,9H).\",\n          \"refs\": null\n      }\n  ]\n}\n```\n"
    },
    {
      "role": "human",
      "content": "\n# Input Text #\n97% yield) as a off white solid.LCMS Method 4:retention time =1.47 min.;observed ion\n=285.7. lH NMR (500 MHz, CHLOROFORM-d) δ 8.56 (s, 1H), 2.72 (s, 3H).\n<scheme id=p13.i3>\n| id             | reactant      | condition   | product       |\n|:---------------|:--------------|:------------|:--------------|\n| page13.scheme1 | page_13.mol_2 |             | page_13.mol_3 |\n</scheme>\n<text id=p13.i4>\nTo a 25 mL RB flask equipped with a stir bar and placed under N2 was added THF\n(9ml) and 3,5-dibromo-4-chloro-2-methylpyridine(1.0g,3.5 mmol).The mixture was\nwarmed to 60 °C. To the solution was added isopropylmagnesium chloride (2 M solution\nin THF)(1.8 ml, 3.7 mmol) dropwise at 60°C. The solution was stirred for 1 minute.Then,\nto the solution was added bis(methylthio)copper(III) bromide (83 mg, 0.350 mmol) (copper\nbromide dimethylsulfide complex) as a solid at once. The solution was stirred at rt for 5\nmin. Then, to a dry 50 mL rb flask equipped with a stir bar and placed under N2 atm was\nadded THF (9 ml) and isopropyl 2-chloro-2-oxoacetate (580 mg,3.85 mmol). The flask\nwas placed in a -78 ℃ bath and was stirred for 10 min. To the flask was added the\norganometallic suspension/solution prepared above via addition funnel. The mixture\nremained a suspension of fine black precipitate and a pale orange solution. The bath was\nallowed to warm to rt with stirring. LCMS analysis after 1.5h found a peak with the\nexpected product mass. Then,to the reaction mixture was added diethanolamine (403 ul,\n4.21 mmol,(the diethanolamine is expected to coordinate both the Cu and the Mg) The\nmixture was transfered to a separatory funnel using water and Et2O. The mixture was\ndiluted with water and was extracted with Et2O. The combined organics were washed with\nbrine; dried over Na2SO4 and filtered. The solution was concentraed in vacuo. The\nresulting residue was dissolved in a minimal of acetone and then concentrated onto celite in\n</text>\n<text id=p14.i0>\nvacuo.The resulting powder was subjected to SiO2 purification.(Biotage,EtOAc/hexanes\ngradient, 0-40% over 10 CVs). The first peak to elute is the desired minor isomer:\nisopropyl 2-(5-bromo-4-chloro-2-methylpyridin-3-yl)-2-oxoacetate (186 mg, 0.580 mmol,\n16.56% yield). LCMS Method 4:retention time=1.33 min.;observed ion =320.0,322.0\nlH NMR (500 MHz, METHANOL-d4) δ 8.63 (s, 1H), 4.33 (spt, J=6.6 Hz, 1H),2.82 (s,\n3H), 1.72 - 1.68 (m,6H).\n</text>\n<text id=p14.i3>\nGeneral Procedure A\n</text>\n\n**JSON Output:**\n"
    }
  ],
  "output": {
    "results": [
      {
        "compound_id": "",
        "iupac_name": "isopropyl 2-(5-bromo-4-chloro-2-methylpyridin-3-yl)-2-oxoacetate",
        "structure_id": "page_13.mol_3",
        "detail_ids": [
          "p13.i4",
          "p14.i0"
        ],
        "detail": "To a 25 mL RB flask equipped with a stir bar and placed under N2 was added THF (9ml) and 3,5-dibromo-4-chloro-2-methylpyridine(1.0g,3.5 mmol).The mixture was warmed to 60 °C. To the solution was added isopropylmagnesium chloride (2 M solution in THF)(1.8 ml, 3.7 mmol) dropwise at 60°C. The solution was stirred for 1 minute.Then, to the solution was added bis(methylthio)copper(III) bromide (83 mg, 0.350 mmol) (copper bromide dimethylsulfide complex) as a solid at once. The solution was stirred at rt for 5 min. Then, to a dry 50 mL rb flask equipped with a stir bar and placed under N2 atm was added THF (9 ml) and isopropyl 2-chloro-2-oxoacetate (580 mg,3.85 mmol). The flask was placed in a -78 °C bath and was stirred for 10 min. To the flask was added the organometallic suspension/solution prepared above via addition funnel. The mixture remained a suspension of fine black precipitate and a pale orange solution. The bath was allowed to warm to rt with stirring. LCMS analysis after 1.5h found a peak with the expected product mass. Then,to the reaction mixture was added diethanolamine (403 ul, 4.21 mmol,(the diethanolamine is expected to coordinate both the Cu and the Mg) The mixture was transfered to a separatory funnel using water and Et2O. The mixture was diluted with water and was extracted with Et2O. The combined organics were washed with brine; dried over Na2SO4 and filtered. The solution was concentraed in vacuo. The resulting residue was dissolved in a minimal of acetone and then concentrated onto celite in vacuo.The resulting powder was subjected to SiO2 purification.(Biotage,EtOAc/hexanes gradient, 0-40% over 10 CVs). The first peak to elute is the desired minor isomer: isopropyl 2-(5-bromo-4-chloro-2-methylpyridin-3-yl)-2-oxoacetate (186 mg, 0.580 mmol, 16.56% yield). LCMS Method 4:retention time=1.33 min.;observed ion =320.0,322.0 lH NMR (500 MHz, METHANOL-d4) δ 8.63 (s, 1H), 4.33 (spt, J=6.6 Hz, 1H),2.82 (s, 3H), 1.72 - 1.68 (m,6H).",
        "refs": null
      }
    ]
  },
  "predict_output": {
    "results": [
      {
        "compound_id": "",
        "iupac_name": "isopropyl 2-(5-bromo-4-chloro-2-methylpyridin-3-yl)-2-oxoacetate",
        "structure_id": "page_13.mol_3",
        "detail_ids": [
          "p13.i4",
          "p14.i0"
        ],
        "detail": "To a 25 mL RB flask equipped with a stir bar and placed under N2 was added THF (9ml) and 3,5-dibromo-4-chloro-2-methylpyridine(1.0g,3.5 mmol).The mixture was warmed to 60 °C. To the solution was added isopropylmagnesium chloride (2 M solution in THF)(1.8 ml, 3.7 mmol) dropwise at 60°C. The solution was stirred for 1 minute.Then, to the solution was added bis(methylthio)copper(III) bromide (83 mg, 0.350 mmol) (copper bromide dimethylsulfide complex) as a solid at once. The solution was stirred at rt for 5 min. Then, to a dry 50 mL rb flask equipped with a stir bar and placed under N2 atm was added THF (9 ml) and isopropyl 2-chloro-2-oxoacetate (580 mg,3.85 mmol). The flask was placed in a -78 ℃ bath and was stirred for 10 min. To the flask was added the organometallic suspension/solution prepared above via addition funnel. The mixture remained a suspension of fine black precipitate and a pale orange solution. The bath was allowed to warm to rt with stirring. LCMS analysis after 1.5h found a peak with the expected product mass. Then,to the reaction mixture was added diethanolamine (403 ul, 4.21 mmol,(the diethanolamine is expected to coordinate both the Cu and the Mg) The mixture was transfered to a separatory funnel using water and Et2O. The mixture was diluted with water and was extracted with Et2O. The combined organics were washed with brine; dried over Na2SO4 and filtered. The solution was concentraed in vacuo. The resulting residue was dissolved in a minimal of acetone and then concentrated onto celite in vacuo.The resulting powder was subjected to SiO2 purification.(Biotage,EtOAc/hexanes gradient, 0-40% over 10 CVs). The first peak to elute is the desired minor isomer: isopropyl 2-(5-bromo-4-chloro-2-methylpyridin-3-yl)-2-oxoacetate (186 mg, 0.580 mmol, 16.56% yield). LCMS Method 4:retention time=1.33 min.;observed ion =320.0,322.0 lH NMR (500 MHz, METHANOL-d4) δ 8.63 (s, 1H), 4.33 (spt, J=6.6 Hz, 1H),2.82 (s, 3H), 1.72 - 1.68 (m,6H).",
        "refs": null
      }
    ]
  },
  "llm_response": "```json\n{\n  \"results\": [\n    {\n      \"compound_id\": \"\",\n      \"iupac_name\": \"isopropyl 2-(5-bromo-4-chloro-2-methylpyridin-3-yl)-2-oxoacetate\",\n      \"structure_id\": \"page_13.mol_3\",\n      \"detail_ids\": [\n        \"p13.i4\",\n        \"p14.i0\"\n      ],\n      \"detail\": \"To a 25 mL RB flask equipped with a stir bar and placed under N2 was added THF (9ml) and 3,5-dibromo-4-chloro-2-methylpyridine(1.0g,3.5 mmol).The mixture was warmed to 60 °C. To the solution was added isopropylmagnesium chloride (2 M solution in THF)(1.8 ml, 3.7 mmol) dropwise at 60°C. The solution was stirred for 1 minute.Then, to the solution was added bis(methylthio)copper(III) bromide (83 mg, 0.350 mmol) (copper bromide dimethylsulfide complex) as a solid at once. The solution was stirred at rt for 5 min. Then, to a dry 50 mL rb flask equipped with a stir bar and placed under N2 atm was added THF (9 ml) and isopropyl 2-chloro-2-oxoacetate (580 mg,3.85 mmol). The flask was placed in a -78 ℃ bath and was stirred for 10 min. To the flask was added the organometallic suspension/solution prepared above via addition funnel. The mixture remained a suspension of fine black precipitate and a pale orange solution. The bath was allowed to warm to rt with stirring. LCMS analysis after 1.5h found a peak with the expected product mass. Then,to the reaction mixture was added diethanolamine (403 ul, 4.21 mmol,(the diethanolamine is expected to coordinate both the Cu and the Mg) The mixture was transfered to a separatory funnel using water and Et2O. The mixture was diluted with water and was extracted with Et2O. The combined organics were washed with brine; dried over Na2SO4 and filtered. The solution was concentraed in vacuo. The resulting residue was dissolved in a minimal of acetone and then concentrated onto celite in vacuo.The resulting powder was subjected to SiO2 purification.(Biotage,EtOAc/hexanes gradient, 0-40% over 10 CVs). The first peak to elute is the desired minor isomer: isopropyl 2-(5-bromo-4-chloro-2-methylpyridin-3-yl)-2-oxoacetate (186 mg, 0.580 mmol, 16.56% yield). LCMS Method 4:retention time=1.33 min.;observed ion =320.0,322.0 lH NMR (500 MHz, METHANOL-d4) δ 8.63 (s, 1H), 4.33 (spt, J=6.6 Hz, 1H),2.82 (s, 3H), 1.72 - 1.68 (m,6H).\",\n      \"refs\": null\n    }\n  ]\n}\n```",
  "model": "PatentSynthesisRouteAgent_gpt-4",
  "status": "",
  "name": "",
  "header_name": ""
},
{
  "id": "page26.scheme0",
  "input": [
    {
      "role": "system",
      "content": "\nYou are a chemical synthesis extraction agent. Extract **each synthesis step** from chemical patent text, with no inference across steps. Preserve wording and IDs exactly.\n\n# Input\nPatent text is tagged as:\n- <text id=...> ... </text>\n- <mol id=...> ... </mol>\n- <table id=...> ... </table>\n- <scheme id=...> ... </scheme>\nTags are top-level, ordered, and IDs must not be changed.\n\n# Extraction Fields\n1. compound_id  \n   - Use explicit product labels (e.g., \"Compound 2\", \"Intermediate A\").  \n   - If only section title defines the final product, assign section title (only last step).  \n   - Otherwise \"\".\n2. iupac_name  \n   - Use if explicitly given; otherwise \"\". No inference.\n3. structure_id  \n   - Only link <mol> ID if it shows the **final product** of the whole Example/Section. Else \"\".\n4. detail_ids  \n   - List of <text id=...> blocks describing procedure (exclude pure analytical data).\n5. detail  \n   - Concatenated verbatim text of detail_ids. No paraphrasing.\n6. refs  \n   - Compound identifiers referenced as inputs. Use exact labels. If none, null.\n\n# Output Format\n```json\n{\n  \"results\": [\n    {\n      \"compound_id\": \"...\",\n      \"iupac_name\": \"...\",\n      \"structure_id\": \"...\",\n      \"detail_ids\": [\"...\"],\n      \"detail\": \"...\",\n      \"refs\": [...] or null\n    }\n  ]\n}\n```\n\n# Rules\n1. One record per step; split at \"Step\" or clear process transitions.\n2. Never merge steps.\n3. No cross-step inference.\n4. Use section title as compound_id only for the last product-forming step.\n5. Accept phrases like \"title compound\" only as reference, not as identifiers.\n\n# Restriction\n1. Retain all <sub> and <sup> tags and their contents exactly as in the source text.\n\n\n## fewshot\nInput:\n```\n<text id=p43.i5>\nExample 37\n</text>\n<mol id=p43.i6>\npage_43.mol_0\n</mol>\n<text id=p43.i7>\n(S)-2-tert-Butoxy-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-2,3'-\nbipyridin-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (50 mg,0.103\nmmol) in DMF (10 mL) was added K2CO3(14.29 mg,0.103 mmol) and 1-bromobutane\n(14.17 mg,0.103 mmol). Then, the mixture was stirred for 20 hours at 45 °℃ and diluted\nwith water and ethyl acetate (30 mL). Organic layer separated, washed with brine (20 mL),\ndried over Na2SO4 and concentrated to obtain a crude product, which was purified by silica\n</text>\n<text id=p44.i0>\ngel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford\nisopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-\n[2,3'-bipyridin]-5'-yl)acetate (43 mg, 0.080 mmol, 77% yield) as a yellow oil.LCMS(M+\nH)=540.2; Retention time (10 mM NH4HCO3)=2.758.\n</text>\n<text id=p44.i1>\nStep 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (52 mg, 0.096 mmol) in\nmethanol (10 mL) and water (2 mL) was added sodium hydroxide (11.56 mg, 0.289 mmol)\nand stirred for 20 hours at 100°C.The mixture was concentrated under vacuo, diluted with\nHCl (1N,0.5 ml), extracted with ethyl acetate (5 ml) and concentrated to give crude\nproduct. The crude product was purified by Prep-HPLC {Instrument Gilson 281 (PHG-\n009); Column Xtimate Prep C18 OBD,21.2 x 250 mm,10 um; Mobile Phase A:water (10\nmM NH4HCO3); B:MeCN; Gradient 40-68%B in 8.0 min,stop at 13.0 min; Flow Rate\n(ml/min)30.00} togive (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-\nyl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetic acid (21.6 mg,0.042 mmol, 43.9 % yield) as\nwhite solid.LCMS(M+H)=498.1; Retention time(10 mM NH4HCO3)=1.716.lH\nNMR(400 MHz,MeOD)δ8.36(d,J=2.8Hz,1H), 8.17(s,1H), 7.56(dd, J=8.6,2.9 Hz,\n1H),7.47(d,J=8.6Hz,1H),5.82(s,1H),4.16(t,J=6.4Hz,2H),2.30-2.66(m,7H),\n1.91-1.77(m,2H),1.64-1.25(m,8H),1.21(s,9H),1.04(t,J=7.4Hz,3H),0.88-0.77\n(m, 6H).\n</text>\n<text id=p44.i4>\nExample 38\n</text>\n<mol id=p44.i5>\npage_44.mol_0\n</mol>\n<text id=p44.i6>\n(S)-2-tert-Butoxy-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-6'-methyl-2,3'-bipyridin-5'-yl)acetic acid\nStep 1: To a solution of 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethan-1-ol (250 mg,1.783\nmmol) and triethylamine (271 mg,2.68 mmol) in DCM (10 mL) was added methanesulfonyl\nchloride (225 mg, 1.962 mmol) at 0°℃. The mixture was stirred at rt for 1 h. The mixture\nwas taken up into aqueous Na2CO3 (20 mL) and extracted with DCM (10 ml X 3). The\n</text>\n<text id=p45.i0>\ncombined organic layers were washed with brine, dried over Na2SO4, concentrated to afford\n2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl methanesulfonate (300 mg, 1.100 mmol, 61.7 %\nyield) as oil which was used in the next step without further purification. LCMS: retention\ntime = 1.22 min, m/z = 219 [M+H]<sup>+</sup>, purity: 80% (214 nm).\n</text>\n<text id=p45.i1>\nStep 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-\nmethylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (50 mg, 0.103\nmmol) in DMF (10 mL) was added K<sub>2</sub>CO<sub>3</sub> (71.4 mg, 0.517 mmol) and 2-(1,3-dimethyl-\n1H-pyrazol-4-yl)ethyl methanesulfonate (67.7 mg, 0.310 mmol). Then, the mixture was\nstirred for 20 hours at 45 °C and diluted with water and ethyl acetate (30 mL). Organic\nlayer separated, washed with brine (20 mL), dried over Na2SO<sub>4</sub> and concentrated to obtain\na crude product, which was purified by silica gel chromatography eluting with ethyl\nacetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (S)-2-(tert-butoxy)-2-(5-(2-\n(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-\nbipyridin]-5'-yl)acetate (41 mg, 0.068 mmol, 65.5 % yield) as a yellow oil. LCMS (M + H)\n= 606.2; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 2.234.\n</text>\n<text id=p45.i3>\nStep 3: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-\npyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-\nyl)acetate (41 mg, 0.068 mmol) in methanol (10 mL) and water (2 mL) was added sodium\nhydroxide (8.12 mg, 0.203 mmol) and stirred for 20 hours at 100 °C. The mixture was\nconcentrated under vacuo, diluted with HCl (1N, 0.5 ml), extracted with ethyl acetate (5\nml) and concentrated to give crude product. The crude product was purified by Prep-HPLC\n{Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2 x 250 mm, 10\num; Mobile Phase A: water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0\nmin, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (S)-2-(tert-butoxy)-2-(5-(2-(1,3-\ndimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-\nbipyridin]-5'-yl) acetic acid (17.3 mg, 0.031 mmol, 45.3 % yield) as white solid. LCMS (M\n+ H) = 564.2; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 1.452. <sup>1</sup>H NMR (400 MHz, MeOD) δ\n8.38 (d, J = 2.7 Hz, 1H), 8.16 (s, 1H), 7.56 (dd, J = 8.6, 2.9 Hz, 1H), 7.47 (d, J = 7.8 Hz,\n2H), 5.82 (s, 1H), 4.25 (t, J = 6.7 Hz, 2H), 3.80 (s, 3H), 3.23-2.57 (m, 9H), 2.25 (s, 3H),\n1.61-1.23 (m, 6H), 1.21 (s, 9H), 0.87- 0.74 (m, 6H).\n</text>\n```\nOutput:\n```json\n{\n    \"results\": [\n        {\n        \"compound_id\": \"Example 37.Step 1\",\n        \"iupac_name\": \"isopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate\",\n        \"structure_id\": \"\",\n        \"detail_ids\": [\n            \"p43.i7\",\n            \"p44.i0\"\n        ],\n        \"detail\": \"Step 1: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-methylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (50 mg,0.103 mmol) in DMF (10 mL) was added K2CO3(14.29 mg,0.103 mmol) and 1-bromobutane (14.17 mg,0.103 mmol). Then, the mixture was stirred for 20 hours at 45 °℃ and diluted with water and ethyl acetate (30 mL). Organic layer separated, washed with brine (20 mL), dried over Na2SO4 and concentrated to obtain a crude product, which was purified by silica\ngel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (43 mg, 0.080 mmol, 77% yield) as a yellow oil.LCMS(M+ H)=540.2; Retention time (10 mM NH4HCO3)=2.758.\",\n        \"refs\": null\n        },\n        {\n        \"compound_id\": \"Example 37.Step2\",\n        \"iupac_name\": \"(S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetic acid\",\n        \"structure_id\": \"page_43.mol_0\",\n        \"detail_ids\": [\n            \"p44.i1\"\n        ],\n        \"detail\": \"Step 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (52 mg, 0.096 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide (11.56 mg, 0.289 mmol) and stirred for 20 hours at 100°C.The mixture was concentrated under vacuo, diluted with HCl (1N,0.5 ml), extracted with ethyl acetate (5 ml) and concentrated to give crude product. The crude product was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD,21.2 x 250 mm,10 um; Mobile Phase A:water (10 mM NH4HCO3); B:MeCN; Gradient 40-68%B in 8.0 min,stop at 13.0 min; Flow Rate (ml/min)30.00} togive (S)-2-(tert-butoxy)-2-(5-butoxy-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetic acid (21.6 mg,0.042 mmol, 43.9 % yield) as white solid.LCMS(M+H)=498.1; Retention time(10 mM NH4HCO3)=1.716.lH NMR(400 MHz,MeOD)δ8.36(d,J=2.8Hz,1H), 8.17(s,1H), 7.56(dd, J=8.6,2.9 Hz, 1H),7.47(d,J=8.6Hz,1H),5.82(s,1H),4.16(t,J=6.4Hz,2H),2.30-2.66(m,7H), 1.91-1.77(m,2H),1.64-1.25(m,8H),1.21(s,9H),1.04(t,J=7.4Hz,3H),0.88-0.77 (m, 6H).\",\n        \"refs\": null\n        },\n        {\n        \"compound_id\": \"Example 38.Step 1\",\n        \"iupac_name\": \"2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl methanesulfonate\",\n        \"structure_id\": \"\",\n        \"detail_ids\": [\n            \"p44.i6\",\n            \"p45.i0\"\n        ],\n        \"detail\": \"Step 1: To a solution of 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethan-1-ol (250 mg,1.783 mmol) and triethylamine (271 mg,2.68 mmol) in DCM (10 mL) was added methanesulfonyl chloride (225 mg, 1.962 mmol) at 0°℃. The mixture was stirred at rt for 1 h. The mixture was taken up into aqueous Na2CO3 (20 mL) and extracted with DCM (10 ml X 3). The\ncombined organic layers were washed with brine, dried over Na2SO4, concentrated to afford 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl methanesulfonate (300 mg, 1.100 mmol, 61.7 % yield) as oil which was used in the next step without further purification. LCMS: retention time = 1.22 min, m/z = 219 [M+H]<sup>+</sup>, purity: 80% (214 nm).\",\n        \"refs\": null\n        },\n        {\n        \"compound_id\": \"Example 38.Step 2\",\n        \"iupac_name\": \"isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate\",\n        \"structure_id\": \"\",\n        \"detail_ids\": [\n            \"p45.i1\"\n        ],\n        \"detail\": \"Step 2: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(4'-(4-ethyl-4-methylpiperidin-1-yl)-5-hydroxy-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (50 mg, 0.103 mmol) in DMF (10 mL) was added K<sub>2</sub>CO<sub>3</sub> (71.4 mg, 0.517 mmol) and 2-(1,3-dimethyl-1H-pyrazol-4-yl)ethyl methanesulfonate (67.7 mg, 0.310 mmol). Then, the mixture was stirred for 20 hours at 45 °C and diluted with water and ethyl acetate (30 mL). Organic layer separated, washed with brine (20 mL), dried over Na2SO<sub>4</sub> and concentrated to obtain a crude product, which was purified by silica gel chromatography eluting with ethyl acetate/petroleum ether (from 10:1 to 1:1) to afford isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (41 mg, 0.068 mmol, 65.5 % yield) as a yellow oil. LCMS (M + H) = 606.2; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 2.234.\",\n        \"refs\": null\n        },\n        {\n        \"compound_id\": \"Example 38.Step 3\",\n        \"iupac_name\": \"(S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl) acetic acid\",\n        \"structure_id\": \"page_44.mol_0\",\n        \"detail_ids\": [\n            \"p45.i3\"\n        ],\n        \"detail\": \"Step 3: To a solution of isopropyl (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl)acetate (41 mg, 0.068 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide (8.12 mg, 0.203 mmol) and stirred for 20 hours at 100 °C. The mixture was concentrated under vacuo, diluted with HCl (1N, 0.5 ml), extracted with ethyl acetate (5 ml) and concentrated to give crude product. The crude product was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2 x 250 mm, 10 um; Mobile Phase A: water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (S)-2-(tert-butoxy)-2-(5-(2-(1,3-dimethyl-1H-pyrazol-4-yl)ethoxy)-4'-(4-ethyl-4-methylpiperidin-1-yl)-6'-methyl-[2,3'-bipyridin]-5'-yl) acetic acid (17.3 mg, 0.031 mmol, 45.3 % yield) as white solid. LCMS (M + H) = 564.2; Retention time (10 mM NH<sub>4</sub>HCO<sub>3</sub>) = 1.452. <sup>1</sup>H NMR (400 MHz, MeOD) δ 8.38 (d, J = 2.7 Hz, 1H), 8.16 (s, 1H), 7.56 (dd, J = 8.6, 2.9 Hz, 1H), 7.47 (d, J = 7.8 Hz, 2H), 5.82 (s, 1H), 4.25 (t, J = 6.7 Hz, 2H), 3.80 (s, 3H), 3.23-2.57 (m, 9H), 2.25 (s, 3H), 1.61-1.23 (m, 6H), 1.21 (s, 9H), 0.87- 0.74 (m, 6H).\",\n        \"refs\": null\n        }\n    ]\n}\n```\n\n## fewshot\n1. refs is only used to record other compound identifiers explicitly referenced during the synthesis of this product (e.g., Example XX). If no such identifiers are mentioned, set refs: null.\nInput:\n```\n<scheme id=p12.i9>\n| id             | reactant      | condition   | product       |\n|:---------------|:--------------|:------------|:--------------|\n| page12.scheme0 | page_12.mol_0 |             | page_12.mol_1 |\n</scheme>\n<text id=p12.i10>\nTo a stirred solution of 2-methylpyridin-4-ol (8.0 g, 73 mmol)in dichloromethane\n(90 ml) and MeOH(11 ml) was added tert-butylamine (15.7 ml,148 mmol) and the\nmixture was cooled to 0 °C. Bromine (7.55 ml,147 mmol) was added dropwise over a 20\nminute period. The reaction mixture was stirred at rt for 2 hours. Then the resulting slurry\nwas filtered through a buchner funnel and the solid was washed with methanol (100 ml)\nand dried overnight to afford 3,5-dibromo-2-methylpyridin-4-ol (10g,37.5 mmol, 51.1%\nyield). LCMS Method 4:retention time = 0.704 min.; observed ion =267.8.lH NMR (500\nMHz,DMSO-d6)δ12.33(brs,1H),8.21(s,1H),2.40(s,3H).\n</text>\n```\nOutput:\n```json\n{\n    \"results\": [\n        {\n        \"compound_id\": \"\",\n        \"iupac_name\": \"3,5-dibromo-2-methylpyridin-4-ol\",\n        \"structure_id\": \"page_12.mol_1\",\n        \"detail_ids\": [\n            \"p12.i10\"\n        ],\n        \"detail\": \"To a stirred solution of 2-methylpyridin-4-ol (8.0 g, 73 mmol)in dichloromethane (90 ml) and MeOH(11 ml) was added tert-butylamine (15.7 ml,148 mmol) and the mixture was cooled to 0 °C. Bromine (7.55 ml,147 mmol) was added dropwise over a 20 minute period. The reaction mixture was stirred at rt for 2 hours. Then the resulting slurry was filtered through a buchner funnel and the solid was washed with methanol (100 ml) and dried overnight to afford 3,5-dibromo-2-methylpyridin-4-ol (10g,37.5 mmol, 51.1% yield). LCMS Method 4:retention time = 0.704 min.; observed ion =267.8.lH NMR (500 MHz,DMSO-d6)δ12.33(brs,1H),8.21(s,1H),2.40(s,3H).\",\n        \"refs\": null\n        }\n    ]\n}\n```\n\n## fewshot2\nThe current structure follows the following format:  \n1. First, this is an isomer example, with the Example Name shown at the top.  \n2. Under this Example, there are multiple Step blocks. Each step must use the top Example Name as the prefix in `compound_id`.  \n3. Each step corresponds to one product, so all steps must be separated into individual records.  \n4. The final step has associated structures. Both must be mapped back to the same Example Name, but output as separate records.  \nInput:\n```\n<text id=p75.i8>\nExample 65 and 66\n</text>\n<mol id=p76.i0>\npage_76.mol_0; page_76.mol_1\n</mol>\n<text id=p76.i1>\nFirst eluting isomer Second eluting isomer\n2S)-2-(tert-Butoxy)-2-(5-(cyclopropylmetl-xy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-\nyl)-[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate(50 mg,0.101 mmol)in\nDMF (10 mL) was added K2CO3 (41.8 mg, 0.303 mmol) and (bromomethyl)cyclopropane\n(27.2 mg,0.202 mmol). The mixture was stirred for 20 hours at 45°℃, diluted with water\nand ethyl acetate(30 mL),organic layer separated, washed with brine (20 mL),dried over\nNa2SO4 and concentrated to obtain a crude product which was purified by silica gel\nchromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1) to afford\nisopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (53 mg, 0.084 mmol, 84 %\nyield) as yellow oil. LCMS (M+H)=550.2; Retention time (10 mM NH4HCO3)=2.705\nmin.\n</text>\n<text id=p76.i5>\nStep 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-\n6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (52 mg,0.095\nmmol) in methanol (10 mL)and water (2 mL) was added sodium hydroxide (7.57 mg,\n0.189 mmol) and stirred for 20 hours at 100°C. The mixture was concentrated under\nvacuo, diluted with HCl (1N, 0.5 ml) and ethyl acetate (5ml). Organic layer separated and\nconcentrated to give crude product which was purified by Prep-HPLC {Instrument Gilson\n281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x250 mm, 10 um; Mobile Phase\nA: Water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0 min, stop at 13.0 min;\nFlow Rate (ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-\nmethyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (34.9 mg,\n0.069 mmol, 72.7% yield) as white solid.LCMS(M+H)=508.2; Retention time (10 mM\nNH4HCO3)=1.592 min.\n</text>\n<text id=p76.i7>\nStep 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-\nmethyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (32.1 mg,\n</text>\n<text id=p77.i0>\n0.063 mmol) were separated by SFC [Column AD-H 4.6x 100 mm; 5 um; Co-Solvent\nEtOH (1%ammonia/methanol)] to obtain\nFirst eluting diastereomer 65:(9.6 mg, 0.019 mmol,29.9% yield).LCMS(M+H)=\n508.2;Retention time (10 mM NH4HCO3) =1.605 min. lHNMR (400 MHz, MeOD) δ\n8.35(d,J=2.8Hz,1H),8.11 (s,1H), 7.54(dd,J=8.6,2.9 Hz, 1H), 7.45(d, J=8.6 Hz,\n1H),5.80(s,1H),4.00(d,J=7.0Hz,2H),2.66(s,3H),2.31-1.25(m,17H),1.18(s,9H),\n0.74-0.65(m,2H),0.50-0.34(m,2H)and\nSecond eluting diastereomer 66: (6.3 mg, 0.012 mmol, 19.63 % yield).LCMS (M+H)=\n508.0; Retention time (10 mM NH4HCO3) = 1.595 min. lH NMR (400 MHz, MeOD) δ\n8.23(d,J=2.7Hz,1H),7.98(s,1H),7.42(dd,J=8.6,2.8Hz,1H),7.33(d,J=8.6Hz,\n1H),5.78(s,1H),3.94-3.84(m,2H),2.52(s,3H),2.18-1.12(m,17H),1.07(s,9H),\n0.62-0.52(m,2H),0.31(q,J=4.6Hz,2H).\n</text>\n```\nOutput:\n```json\n{\n  \"results\": [\n      {\n          \"compound_id\": \"Example 65 and 66.Step 1\",\n          \"iupac_name\": \"isopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate\",\n          \"structure_id\": \"\",\n          \"detail_ids\": [\n              \"p76.i1\"\n          ],\n          \"detail\": \"Step 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate(50 mg,0.101 mmol)in DMF (10 mL) was added K2CO3 (41.8 mg, 0.303 mmol) and (bromomethyl)cyclopropane (27.2 mg,0.202 mmol). The mixture was stirred for 20 hours at 45°℃, diluted with water and ethyl acetate(30 mL),organic layer separated, washed with brine (20 mL),dried over Na2SO4 and concentrated to obtain a crude product which was purified by silica gel chromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1) to afford isopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (53 mg, 0.084 mmol, 84 % yield) as yellow oil. LCMS (M+H)=550.2; Retention time (10 mM NH4HCO3)=2.705 min.\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 65 and 66.Step 2\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"\",\n          \"detail_ids\": [\n              \"p76.i5\"\n          ],\n          \"detail\": \"Step 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (52 mg,0.095 mmol) in methanol (10 mL)and water (2 mL) was added sodium hydroxide (7.57 mg, 0.189 mmol) and stirred for 20 hours at 100°C. The mixture was concentrated under vacuo, diluted with HCl (1N, 0.5 ml) and ethyl acetate (5ml). Organic layer separated and concentrated to give crude product which was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x250 mm, 10 um; Mobile Phase A: Water (10 mM NH4HCO3); B: MeCN; Gradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (34.9 mg, 0.069 mmol, 72.7% yield) as white solid.LCMS(M+H)=508.2; Retention time (10 mM NH4HCO3)=1.592 min.\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 65 and 66.Step 3\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"page_76.mol_0\",\n          \"detail_ids\": [\n              \"p76.i7\",\n              \"p77.i0\"\n          ],\n          \"detail\": \"Step 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (32.1 mg,\n0.063 mmol) were separated by SFC [Column AD-H 4.6x 100 mm; 5 um; Co-Solvent EtOH (1%ammonia/methanol)] to obtain\nFirst eluting diastereomer 65:(9.6 mg, 0.019 mmol,29.9% yield).LCMS(M+H)= 508.2;Retention time (10 mM NH4HCO3) =1.605 min. lHNMR (400 MHz, MeOD) δ 8.35(d,J=2.8Hz,1H),8.11 (s,1H), 7.54(dd,J=8.6,2.9 Hz, 1H), 7.45(d, J=8.6 Hz, 1H),5.80(s,1H),4.00(d,J=7.0Hz,2H),2.66(s,3H),2.31-1.25(m,17H),1.18(s,9H), 0.74-0.65(m,2H),0.50-0.34(m,2H)and Second eluting diastereomer 66: (6.3 mg, 0.012 mmol, 19.63 % yield).LCMS (M+H)= 508.0; Retention time (10 mM NH4HCO3) = 1.595 min. lH NMR (400 MHz, MeOD) δ 8.23(d,J=2.7Hz,1H),7.98(s,1H),7.42(dd,J=8.6,2.8Hz,1H),7.33(d,J=8.6Hz, 1H),5.78(s,1H),3.94-3.84(m,2H),2.52(s,3H),2.18-1.12(m,17H),1.07(s,9H), 0.62-0.52(m,2H),0.31(q,J=4.6Hz,2H).\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 65 and 66.Step 3\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"page_76.mol_1\",\n          \"detail_ids\": [\n              \"p76.i7\",\n              \"p77.i0\"\n          ],\n          \"detail\": \"Step 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(5-(cyclopropylmethoxy)-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetic acid (32.1 mg,\n0.063 mmol) were separated by SFC [Column AD-H 4.6x 100 mm; 5 um; Co-Solvent EtOH (1%ammonia/methanol)] to obtain\nFirst eluting diastereomer 65:(9.6 mg, 0.019 mmol,29.9% yield).LCMS(M+H)= 508.2;Retention time (10 mM NH4HCO3) =1.605 min. lHNMR (400 MHz, MeOD) δ 8.35(d,J=2.8Hz,1H),8.11 (s,1H), 7.54(dd,J=8.6,2.9 Hz, 1H), 7.45(d, J=8.6 Hz, 1H),5.80(s,1H),4.00(d,J=7.0Hz,2H),2.66(s,3H),2.31-1.25(m,17H),1.18(s,9H), 0.74-0.65(m,2H),0.50-0.34(m,2H)and Second eluting diastereomer 66: (6.3 mg, 0.012 mmol, 19.63 % yield).LCMS (M+H)= 508.0; Retention time (10 mM NH4HCO3) = 1.595 min. lH NMR (400 MHz, MeOD) δ 8.23(d,J=2.7Hz,1H),7.98(s,1H),7.42(dd,J=8.6,2.8Hz,1H),7.33(d,J=8.6Hz, 1H),5.78(s,1H),3.94-3.84(m,2H),2.52(s,3H),2.18-1.12(m,17H),1.07(s,9H), 0.62-0.52(m,2H),0.31(q,J=4.6Hz,2H).\",\n          \"refs\": null\n      }\n  ]\n}\n```\n\n## fewshot3\nThe current structure follows the following format:  \n1. First, this is an isomer example, with the Example Name shown at the top.\n2. Two structure_id values appear sequentially within the <mol> tags.\n3. The final step is associated with two structures. Both must be mapped back to the same Example Name, but output as separate records.\nInput:\n```\n<text id=p81.i1>\nExample 71 and 72\n</text>\n<mol id=p81.i2>\npage_81.mol_0\n</mol>\n<text id=p81.i3>\nFirst eluting isomer\n(2S)-2-(tert-Butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-\npyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\nStep 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (50mg, 0.101 mmol)in (10\nmL) was added K2CO3 (41.8 mg, 0.303 mmol) and 2-(tetrahydro-2H-pyran-4-yl)ethyl\nmethanesulfonate (31.5 mg,0.151 mmol).The mixture was stirred for 20 hours at 45°℃,\ndiluted with water and ethyl acetate(30 mL), organic layer separated, washed with brine\n(20 mL), dried over Na2SO4 and concentrated to obtain a crude product which was purified\nby silica gel chromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1)\nto afford isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-\n(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate (52 mg,0.082 mmol,\n81% yield) as yellow oil. LCMS (M+H)=608.2; Retention time (10 mM NH4HCO3)=\n2.649 min.\n</text>\n<text id=p81.i8>\nStep 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-\n5'-yl)acetate (52 mg, 0.086 mmol) in methanol (10 mL) and water (2 mL) was added\nsodium hydroxide (10.27 mg,0.257 mmol) and stirred for 20 hours at 100°C.The mixture\nwas concentrated under vacuo, diluted with HCl (1N,0.5 ml) and ethyl acetate (5ml).\nOrganic layer separated and concentrated to give crude product which was purified by\n</text>\n<mol id=p81.i11>\npage_81.mol_1\n</mol>\n<text id=p81.i12>\nSecond eluting isomer\n</text>\n<text id=p82.i0>\nPrep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x\n250 mm,10 um;Mobile Phase A: Water(10 mM NH4HCO3);B: MeCN;Gradient 40-\n68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (2S)-2-(tert-\nbutoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-\nyl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (21.5 mg,0.038 mmol, 44.4% yield) as white\nsolid.LCMS (M+H)=566.2;Retention time(10 mM NH4HCO3)=1.560 min.\n</text>\n<text id=p82.i2>\nStep 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-\n(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-\n5'-yl)acetic acid (21.5 mg, 0.038 mmol) were separated by SFC [Column IC (4.6 x 100\nmm; 5 um); Co-Solvent MeOH (0.2%ammonia/methano)] to obtain\nFirst eluting diastereomer 71:(4.5 mg, 7.70 umol, 20.27% yield).LCMS (M+H)=566.1;\nRetention time(10 mM NH4HCO3)=1.558 min.lHNMR(400 MHz,MeOD) 8 8.37(d,J\n=2.8Hz,1H),8.13(s,1H),7.57(dd,J=8.6,2.9Hz,1H),7.46(d,J=8.6Hz,1H),5.82(s,\n1H), 4.23 (t, J=6.2 Hz,2H),3.97(dd, J= 11.1,3.4Hz,2H),3.47(td,J=11.9, 1.9 Hz,\n2H),2.66(s,3H),1.93-1.29(m,23H),1.20(s,9H) and\nSecond eluting diastereomer 72: (3.7mg, 6.54 umol, 17.21 % yield). LCMS (M+H)=\n566.2 ;Retention time (10 mM NH4HCO3)= 1.545 min. lHNMR (400 MHz, MeOD)δ\n8.26(d,J=2.7 Hz,1H),8.03 (s,1H),7.45(dd,J=8.6,2.9 Hz,1H),7.36(d,J=8.6Hz,\n1H),5.83(s,1H),4.11(t,J=6.1Hz,2H),3.85 (dd,J=10.9,3.7Hz,2H),3.34(td, J=\n11.9,2.0Hz,2H),2.52(s,3H),2.13-2.07(m,1H),1.98-1.16(m,23H),1.08(s,9H).\n</text>\n```\nOutput:\n```json\n{\n  \"results\": [\n      {\n          \"compound_id\": \"Example 71 and 72.Step 1\",\n          \"iupac_name\": \"isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate\",\n          \"structure_id\": \"\",\n          \"detail_ids\": [\n              \"p81.i3\"\n          ],\n          \"detail\": \"Step 1: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(5-hydroxy-6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-[2,3'-bipyridin]-5'-yl)acetate (50mg, 0.101 mmol)in (10 mL) was added K2CO3 (41.8 mg, 0.303 mmol) and 2-(tetrahydro-2H-pyran-4-yl)ethyl methanesulfonate (31.5 mg,0.151 mmol).The mixture was stirred for 20 hours at 45°℃, diluted with water and ethyl acetate(30 mL), organic layer separated, washed with brine (20 mL), dried over Na2SO4 and concentrated to obtain a crude product which was purified by silica gel chromatography eluting with ether acetate/ petroleum ether (from 10:1 to 1:1) to afford isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate (52 mg,0.082 mmol, 81% yield) as yellow oil. LCMS (M+H)=608.2; Retention time (10 mM NH4HCO3)= 2.649 min.\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 71 and 72.Step 2\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"\",\n          \"detail_ids\": [\n              \"p81.i8\",\n              \"p82.i0\"\n          ],\n          \"detail\": \"Step 2: To a solution of isopropyl (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetate (52 mg, 0.086 mmol) in methanol (10 mL) and water (2 mL) was added sodium hydroxide (10.27 mg,0.257 mmol) and stirred for 20 hours at 100°C.The mixture was concentrated under vacuo, diluted with HCl (1N,0.5 ml) and ethyl acetate (5ml). Organic layer separated and concentrated to give crude product which was purified by Prep-HPLC {Instrument Gilson 281 (PHG-009); Column Xtimate Prep C18 OBD, 21.2x 250 mm,10 um;Mobile Phase A: Water(10 mM NH4HCO3);B: MeCN;Gradient 40-68%B in 8.0 min, stop at 13.0 min; Flow Rate (ml/min) 30.00} to give (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (21.5 mg,0.038 mmol, 44.4% yield) as white solid.LCMS (M+H)=566.2;Retention time(10 mM NH4HCO3)=1.560 min.\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 71 and 72.Step 3\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"page_81.mol_0\",\n          \"detail_ids\": [\n              \"p82.i2\"\n          ],\n          \"detail\": \"Step 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (21.5 mg, 0.038 mmol) were separated by SFC [Column IC (4.6 x 100 mm; 5 um); Co-Solvent MeOH (0.2%ammonia/methano)] to obtain First eluting diastereomer 71:(4.5 mg, 7.70 umol, 20.27% yield).LCMS (M+H)=566.1; Retention time(10 mM NH4HCO3)=1.558 min.lHNMR(400 MHz,MeOD) 8 8.37(d,J =2.8Hz,1H),8.13(s,1H),7.57(dd,J=8.6,2.9Hz,1H),7.46(d,J=8.6Hz,1H),5.82(s, 1H), 4.23 (t, J=6.2 Hz,2H),3.97(dd, J= 11.1,3.4Hz,2H),3.47(td,J=11.9, 1.9 Hz, 2H),2.66(s,3H),1.93-1.29(m,23H),1.20(s,9H) and Second eluting diastereomer 72: (3.7mg, 6.54 umol, 17.21 % yield). LCMS (M+H)= 566.2 ;Retention time (10 mM NH4HCO3)= 1.545 min. lHNMR (400 MHz, MeOD)δ 8.26(d,J=2.7 Hz,1H),8.03 (s,1H),7.45(dd,J=8.6,2.9 Hz,1H),7.36(d,J=8.6Hz, 1H),5.83(s,1H),4.11(t,J=6.1Hz,2H),3.85 (dd,J=10.9,3.7Hz,2H),3.34(td, J= 11.9,2.0Hz,2H),2.52(s,3H),2.13-2.07(m,1H),1.98-1.16(m,23H),1.08(s,9H).\",\n          \"refs\": null\n      },\n      {\n          \"compound_id\": \"Example 71 and 72.Step 3\",\n          \"iupac_name\": \"(2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid\",\n          \"structure_id\": \"page_81.mol_1\",\n          \"detail_ids\": [\n              \"p82.i2\"\n          ],\n          \"detail\": \"Step 3: The diastereomers of (2S)-2-(tert-butoxy)-2-(6'-methyl-4'-(octahydroisoquinolin-2(1H)-yl)-5-(2-(tetrahydro-2H-pyran-4-yl)ethoxy)-[2,3'-bipyridin]-5'-yl)acetic acid (21.5 mg, 0.038 mmol) were separated by SFC [Column IC (4.6 x 100 mm; 5 um); Co-Solvent MeOH (0.2%ammonia/methano)] to obtain First eluting diastereomer 71:(4.5 mg, 7.70 umol, 20.27% yield).LCMS (M+H)=566.1; Retention time(10 mM NH4HCO3)=1.558 min.lHNMR(400 MHz,MeOD) 8 8.37(d,J =2.8Hz,1H),8.13(s,1H),7.57(dd,J=8.6,2.9Hz,1H),7.46(d,J=8.6Hz,1H),5.82(s, 1H), 4.23 (t, J=6.2 Hz,2H),3.97(dd, J= 11.1,3.4Hz,2H),3.47(td,J=11.9, 1.9 Hz, 2H),2.66(s,3H),1.93-1.29(m,23H),1.20(s,9H) and Second eluting diastereomer 72: (3.7mg, 6.54 umol, 17.21 % yield). LCMS (M+H)= 566.2 ;Retention time (10 mM NH4HCO3)= 1.545 min. lHNMR (400 MHz, MeOD)δ 8.26(d,J=2.7 Hz,1H),8.03 (s,1H),7.45(dd,J=8.6,2.9 Hz,1H),7.36(d,J=8.6Hz, 1H),5.83(s,1H),4.11(t,J=6.1Hz,2H),3.85 (dd,J=10.9,3.7Hz,2H),3.34(td, J= 11.9,2.0Hz,2H),2.52(s,3H),2.13-2.07(m,1H),1.98-1.16(m,23H),1.08(s,9H).\",\n          \"refs\": null\n      }\n  ]\n}\n```\n"
    },
    {
      "role": "human",
      "content": "\n# Input Text #\n*ND= yield not determined. The product was carried directly into the next step\n<scheme id=p26.i2>\n| id             | reactant      | condition                      | product       |\n|:---------------|:--------------|:-------------------------------|:--------------|\n| page26.scheme0 | page_26.mol_3 | 2-methylpropan-1-ol;DIAD, PPh3 | page_26.mol_4 |\n</scheme>\n<text id=p26.i3>\nTo a 500 mL r.b. flask equipped with a large stir bar was added 6-bromopyridin-3-\n5 ol(10.0g,57.5 mmol),2-methylpropan-1-ol(4.26 g, 57.5 mmol),triphenylphosphine (15.8\ng,60.3 mmol) and THF (192 ml). To the stirring solution was added DIAD (11.73 ml,60.3\nmmol) and after 15 min the reaction solution was concentrated in vacuo. To the crude\nreaction product was added hexanes:Et2O(1:1,250 mL) and stirred.A signficant amount\nof crystalline material (Ph3PO) precipitated was removed via filtration. The filtrate was\nconcentrated in vacuo and the residue was dissolved in a minimal of acetone and\nconcentrated onto Celite. The resulting powder was subjected to SiO2 purifciation on the\nBiotage(120 g column) 0-100% 10 CVs to afford 2-bromo-5-isobutoxypyridine (12.7 g,\n96%) as a clear oil. LCMS Method 4: retention time = 1.36 min.; observed ion =230.0,\n232.0.lHNMR(500MHz,CHLOROFORM-d)88.07(d,J=3.0Hz,1H),7.44-7.25(m,\n1H),7.11(dd,J=8.8,3.2Hz,1H),3.76(d,J=6.5Hz,2H),2.17-2.06(m,1H),1.05(d,\nJ=6.8 Hz, 6H).\n</text>\n\n**JSON Output:**\n"
    }
  ],
  "output": {
    "results": [
      {
        "compound_id": "",
        "iupac_name": "2-bromo-5-isobutoxypyridine",
        "structure_id": "page_26.mol_4",
        "detail_ids": [
          "p26.i3"
        ],
        "detail": "To a 500 mL r.b. flask equipped with a large stir bar was added 6-bromopyridin-3-5 ol(10.0g,57.5 mmol),2-methylpropan-1-ol(4.26 g, 57.5 mmol),triphenylphosphine (15.8 g,60.3 mmol) and THF (192 ml). To the stirring solution was added DIAD (11.73 ml,60.3 mmol) and after 15 min the reaction solution was concentrated in vacuo. To the crude reaction product was added hexanes:Et2O(1:1,250 mL) and stirred.A signficant amount of crystalline material (Ph3PO) precipitated was removed via filtration. The filtrate was concentrated in vacuo and the residue was dissolved in a minimal of acetone and concentrated onto Celite. The resulting powder was subjected to SiO2 purifciation on the Biotage(120 g column) 0-100% 10 CVs to afford 2-bromo-5-isobutoxypyridine (12.7 g, 96%) as a clear oil. LCMS Method 4: retention time = 1.36 min.; observed ion =230.0, 232.0.lHNMR(500MHz,CHLOROFORM-d)88.07(d,J=3.0Hz,1H),7.44-7.25(m, 1H),7.11(dd,J=8.8,3.2Hz,1H),3.76(d,J=6.5Hz,2H),2.17-2.06(m,1H),1.05(d, J=6.8 Hz, 6H).",
        "refs": null
      }
    ]
  },
  "predict_output": {
    "results": [
      {
        "compound_id": "",
        "iupac_name": "2-bromo-5-isobutoxypyridine",
        "structure_id": "page_26.mol_4",
        "detail_ids": [
          "p26.i3"
        ],
        "detail": "To a 500 mL r.b. flask equipped with a large stir bar was added 6-bromopyridin-3-5 ol(10.0g,57.5 mmol),2-methylpropan-1-ol(4.26 g, 57.5 mmol),triphenylphosphine (15.8 g,60.3 mmol) and THF (192 ml). To the stirring solution was added DIAD (11.73 ml,60.3 mmol) and after 15 min the reaction solution was concentrated in vacuo. To the crude reaction product was added hexanes:Et2O(1:1,250 mL) and stirred.A signficant amount of crystalline material (Ph3PO) precipitated was removed via filtration. The filtrate was concentrated in vacuo and the residue was dissolved in a minimal of acetone and concentrated onto Celite. The resulting powder was subjected to SiO2 purifciation on the Biotage(120 g column) 0-100% 10 CVs to afford 2-bromo-5-isobutoxypyridine (12.7 g, 96%) as a clear oil. LCMS Method 4: retention time = 1.36 min.; observed ion =230.0, 232.0.lHNMR(500MHz,CHLOROFORM-d)88.07(d,J=3.0Hz,1H),7.44-7.25(m, 1H),7.11(dd,J=8.8,3.2Hz,1H),3.76(d,J=6.5Hz,2H),2.17-2.06(m,1H),1.05(d, J=6.8 Hz, 6H).",
        "refs": null
      }
    ]
  },
  "llm_response": "```json\n{\n    \"results\": [\n        {\n            \"compound_id\": \"\",\n            \"iupac_name\": \"2-bromo-5-isobutoxypyridine\",\n            \"structure_id\": \"page_26.mol_4\",\n            \"detail_ids\": [\n                \"p26.i3\"\n            ],\n            \"detail\": \"To a 500 mL r.b. flask equipped with a large stir bar was added 6-bromopyridin-3-5 ol(10.0g,57.5 mmol),2-methylpropan-1-ol(4.26 g, 57.5 mmol),triphenylphosphine (15.8 g,60.3 mmol) and THF (192 ml). To the stirring solution was added DIAD (11.73 ml,60.3 mmol) and after 15 min the reaction solution was concentrated in vacuo. To the crude reaction product was added hexanes:Et2O(1:1,250 mL) and stirred.A signficant amount of crystalline material (Ph3PO) precipitated was removed via filtration. The filtrate was concentrated in vacuo and the residue was dissolved in a minimal of acetone and concentrated onto Celite. The resulting powder was subjected to SiO2 purifciation on the Biotage(120 g column) 0-100% 10 CVs to afford 2-bromo-5-isobutoxypyridine (12.7 g, 96%) as a clear oil. LCMS Method 4: retention time = 1.36 min.; observed ion =230.0, 232.0.lHNMR(500MHz,CHLOROFORM-d)88.07(d,J=3.0Hz,1H),7.44-7.25(m, 1H),7.11(dd,J=8.8,3.2Hz,1H),3.76(d,J=6.5Hz,2H),2.17-2.06(m,1H),1.05(d, J=6.8 Hz, 6H).\",\n            \"refs\": null\n        }\n    ]\n}\n```",
  "model": "PatentSynthesisRouteAgent_gpt-4",
  "status": "",
  "name": "",
  "header_name": ""
}
]
